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Abstract 
 Many physiological responses are regulated by the pituitary including, but not 
limited to, growth, metabolism, response to stress, and fertility. These responses in the 
anterior lobe are mediated by the release of the following hormones, growth hormone 
(GH), adrenocorticotropic hormone (ACTH), thyroid stimulating hormone (TSH), 
prolactin, (PRL), follicle-stimulating hormone (FSH), and luteinizing hormone (LH), and 
in mice, an additional intermediate lobe produces alpha melanocyte-stimulating hormone 
(MSH) from alternative cleavage of the Pomc gene. The pituitary modulates many of 
these processes in a dynamic manner in response to physiological need. This includes not 
only adjusting hormone secretion, but can also include increasing cellular proliferation to 
meet greater demands. Taken together with the fact that these hormone producing cells 
differentiate in a spatial and temporal specific manner, the pituitary then is a convenient 
model to study cellular differentiation, endocrine cell localization, and progenitor cell 
maintenance. The present work identifies a novel endogenous function for the gene 
Numb, as well as both intrinsic and extrinsic effects of aryl hydrocarbon receptor 
activation, on pituitary hormone producing cells. 
 The adaptor protein Numb was originally described as an important mediator of 
asymmetric cell division during neurogenesis, however in the study described here it is 
shown to have an important cell adhesion function in the post-natal pituitary. Both 
NUMB and related homolog NUMBLIKE, are expressed early in pituitary development 
before hormone cell specification, at which point they become undetectable by 
immunohistochemisty. NUMB expression becomes prominent again after birth in the 
MSH expressing intermediate lobe cells, as well as the gonadotropes in the anterior 
lobe. Full Numb knockout mice (Numb
-/-
) are embryonic lethal before development of the 
pituitary, so the work described here utilized a Cre-loxP conditional knockout system 
driven off the Pomc promoter to delete Numb and Numblike in the intermediate lobe. 
Conditional double knockout animals (cDKO) have metaplastic intermediate lobes with 
impaired localization of adherens junctions proteins including N- and E-cadherin, and 
beta- and alpha-catenin, and strikingly, infiltration by arginine vasopressin secreting 
posterior lobe axons. Last, the Sox2 positive progenitor cell niche is disrupted such that 
these cells become more diffuse throughout the intermediate lobe rather than restricted to 
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the luminal border of the intermediate lobe, as compared to controls. Numb then is 
critical for maintaining proper intermediate lobe cell adhesion and localization. 
 A class of endocrine disruptors includes environmental dioxins, which act by 
binding the aryl hydrocarbon receptor (AhR). These compounds are known for causing 
fertility problems and cancer development, yet little is understood regarding the role of 
AhR in the mammalian pituitary. This work describes the effect of AhR activation on 
endogenous pituitary hormone expression and proliferation in the GH3 rat somato-
lactrotroph cell line. The AhR agonist -naphthoflavone at nanomolar doses impairs 
mRNA and protein expression of PRL, but not GH transcription in GH3 cells. Also, 
when combined with 100 nM of the partial AhR antagonist -naphthoflavone, the 
suppressive effects on PRL were enhanced and GH levels remained unaffected. These 
changes coincide with a suppression of the anti-proliferative signaling cytokine 
TGFbeta1. In knockout studies, we find that female AhR
-/-
 mice have significantly 
reduced LH expression at postnatal day 90. Overall, these results show AhR not only has 
important endogenous effects with respect to normal pituitary function, but also that 
exogenous stimulation through environmental contaminants could lead to significant 
suppression of pituitary hormones. 
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Chapter One: Introduction 
Understanding cell fate determination is important for basic knowledge of normal 
tissue development, but also has implications for disease such as uncontrolled progenitor 
cell proliferation and cancer. Coordination of proper lineage commitment involves an 
immense number of factors each with unique and overlapping functions. However, the 
protein NUMB, originally identified as critical to organ cell precursor development in 
Drosophila (1), deserves particular attention. Numb is not only a critical factor for cell 
lineage determination during development, but also contributes to a wide range of other 
functions that can cause human disease when misregulated. These actions include but are 
not limited to, cell adhesion, migration, cell cycle control, and adaptor activities for 
protein degradation and cell membrane tethering. 
Numb is an evolutionarily conserved gene with some important phylogenetic 
differences. Unlike Drosophila Numb (d-Numb), which exists in one form, mice (m-
Numb) have 4 alternatively spliced isoforms determined by the presence or absence of 
the PTB domain (PTBL or PTBS for long and short) or a proline rich region (PRR) closer 
to the C-terminus (PRRL or PRRS for long and short). These are also sometimes referred 
to by their molecular weights, which are Nbp72, -71, -66, and -65 where 1 kDa and 6 
kDa accounts for the PTB and PRR peptides respectively (Figure 1.1). M-Numb shows 
63.3% homology with d-Numb within the first 292 of 593 amino acids including all key 
residues of a phosphotyrosine binding (PTB) domain, with very little homology in 
remaining amino acids (2). This suggested a key functional role within the PTB region of 
Numb. The significance of the PRR domain is less well understood, but PRR-containing 
forms are enriched in progenitor cells (3-5). 
Numb interacts with proteins involved in endocytosis and can be localized to the 
plasma membrane and intracellular vesicles. The PTB insert (PTBi) is required for Numb 
localization to the plasma membrane (6, 7), and in the absence of PTBi, Numb expression 
is diffuse throughout the cytoplasm(8). This is supported with data showing isolated 
PTBi segments localize to the plasma membrane, yet are not found on vesicles compared 
to the full length Numb protein (9). Protein binding regions within Numb implicated in 
endocytosis include two binding domains for alpha-adaptin and an Eps15 homology (EH) 
containing sequence in the C-terminal region (10, 11). The Eps homology domain 
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includes NPF binding motifs (asparagine-proline-phenylalanine), which are important for 
interactions with critical endocytic protein complexes including proteins within the 
Epsin15 family, involved in cathrin-dependent as well as clathrin-independent 
endocytosis (10-13). Site-directed mutagenesis analysis shows that mutating either the 
first C-terminal alpha-adaptin binding site (DPF) or EH domain disrupts binding to 
Eps15, but does not affect Numb membrane or vesicle localization (9, 12). However, 
removing the C-terminal 38 amino acids containing both DPF sites and EH domain, 
reduced vesicle-associated Numb and caused a generalized cell membrane localization 
(9). This suggests the C-terminal alpha-adaptin and EH domains may work cooperatively 
and are required for vesicle binding. Overall, Numb is an adaptor protein with functions 
requiring multiple protein interactions including, but not limited to, facilitating membrane 
localization and proteosome trafficking of membrane proteins. 
There is also a mammalian homolog to Numb, Numblike, that has 76% identity to 
m-Numb between amino acids 42 and 331. Expression of Numblike in mice is 
predominantly limited to the embryonic and adult nervous system, specifically in post-
mitotic cortical neurons. This contrasts with Numb, which is exclusively found in neural 
progenitors within the ventricular zone during neurogenesis (14), indicating there could 
be some overlap in function, but also that there could be distinct roles for each gene. 
 
Numb function in vivo, Drosophila: 
A better understanding of the protein actions of Numb in mammalian systems 
should first begin with an introduction to its discovery and characterization in 
Drosophila. During neurogenesis in mammals and invertebrates, a very rapid expansion 
and differentiation of daughter cells is tightly controlled and necessary for proper nervous 
system development. While asymmetric division is a cardinal and critical process for the 
development of multiple cell lineages from a single progenitor precursor, symmetric 
divisions are also important to maintain an active progenitor pool and sufficient numbers 
of future differentiated cells. Studies in Drosophila show that differential or asymmetric 
segregation of Numb during division of sensory organ precursor (SOP) cells is required 
for the proper establishment of all subsequent differentiated cell types (1, 15, 16). During 
SOP division a single precursor will yield 4 daughter cells following two divisions. The 
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first division involves an asymmetric division to produce one cell that will divide further 
symmetrically and ultimately produce two outer support cells, while the other precursor 
daughter cell will asymmetrically divide to yield a sheath cell and neuron. During 
precursor division, NUMB preferentially localizes to one half of the membrane and is 
inherited by the cell ultimately responsible for producing the neuron and sheath cell. In 
fact, loss of Drosophila Numb (d-Numb) results in extra support cells concomitant with 
loss of sheath and peripheral neurons (1, 16). Interestingly, introduction of not only d-
Numb but also m-Numb can rescue the sheath cells and peripheral neurons of sensory 
organs. Further, m-Numb co-localizes asymmetrically with d-Numb in SOP cells. Cells 
inheriting NUMB following division may therefore be adopting alternate cell fates due to 
the actions of NUMB in receptor internalization and interactions with endocytic 
machinery. These early Drosophila studies were important to identify Numb and show its 
role in neural cell fate choice through asymmetric distribution. 
 
Numb function in vivo, mouse: 
So far the greatest interest has been focused on Numb actions during 
neurogenesis, however it must be mentioned that evidence is rapidly emerging that Numb 
also plays a critical role in other organ systems as well. The first mouse knockout model 
of Numb showed embryonic lethality at e11.5. These mice have neural tube defects as 
well as precocious forebrain neuron production (17). Interestingly, this phenotype came 
from a targeted deletion including only exons 5 and 6, critical coding sequences for the 
PTB domain, and similar results came shortly after by another group having generated a 
full Numb knockout by deleting the ATG start site (18). These mice also died around 
e11.5 with neural tube defects, however they were also reported to have angiogenic 
defects and possible placental dysfunction. In contrast to the PTB deletion, the full Numb 
knockout mice did not show evidence of enhanced forebrain or midbrain neurogenesis 
and in fact had reduced hindbrain development in addition to impaired peripheral sensory 
neurons. These results suggest the PTB region is critical for early embryogenesis, 
particularly neural tube formation, while other regions of Numb outside of the PTB 
sequence may be partly responsible for the reduced hindbrain formation and angiogenesis 
defects.  
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As previously mentioned, Numblike is distinct from Numb in that it is expressed 
and inherited symmetrically and appears to be limited in expression to post mitotic 
neurons in contrast to progenitor cells (14). The Numblike knockout therefore might be 
predicted to have a very different phenotype than the Numb knockout, however this is not 
the case. The Numblike knockout mouse has no obvious phenotype with the exception of 
lower fertility in females, however the double Numb, Numblike double knockout mouse 
shows similar but more severe phenotype compared to the Numb single mutant mouse 
and so the two genes are treated as functionally redundant (19).  
 Following the discovery of embryonic lethality of the Numb knockouts and neural 
tube defects, three separate neural conditional Numb knockout mice were analyzed, 
yielding conflicting results. The first published knockout utilized the early 
(approximately e8.5) progenitor expressing nestin-Cre recombinase to mediate Numb and 
Numblike excision (19). These mice have an insufficient maintenance of neuronal 
precursors, shown by reduced numbers of BrdU-labeled cells and decreased expression of 
the progenitor marker Hes5. Further, there is a substantial increase in expression of the 
neuronal differentiation marker Hu in these conditional double (Numb Numblike) 
knockout (cDKO) mice (19). Paradoxically, cDKO mice using an Emx-Cre mediated 
excision (expressed e9.5 to e12.5) show progenitor hyperproliferation with impaired 
differentiation and delayed cell cycle exit (20). Last, conditional deletion of Numb on a 
Numblike null background using the D6-Cre beginning at e10.5 in dorsal forebrain 
progenitor cells again shows premature progenitor cell depletion (21). Together, these 
studies support a role for Numb in progenitor maintenance but also for promoting cellular 
differentiation. This is sustantiated by experiments showing that Numb can be segregated 
to neuronal progenitor cells following asymmetric division (2) or to differentiated 
neurons (22). Explanations to account for these disparities could include that the timing 
of Numb deletion is an important consideration, particularly with respect to isoform 
expression. Data show that during neurogenesis PRRL is predominant between e7 and 
e10 and diminishes by e13 while PRRS is detectable throughout neurogenesis and into 
adulthood (3, 8, 23). The PTB region shows a similar trend such that the expression of 
the shorter form is more dominant in mature neurons compared to progenitors (3) and so 
the phenotypes observed may be reflective of deleting differing isoform expressions at 
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different times and tissues. Also, conditional deletion within different cell types may 
affect cellular organization, and mislocalized cells may indirectly affect maintenance of 
the progenitor cell niche (20, 21). Overall, NUMB can promote as well as inhibit 
progenitor cell maintenance, and these functions may be due in part to its function as an 
adaptor protein which facilitates multiple protein interactions. 
 
Numb induces Notch degradation  
While far from well understood, significant progress has been made in recent 
years regarding Numb isoform and conserved protein binding domain functionality. The 
characterization of the PTB region in d-Numb provided insight into how the mouse 
isoforms containing or lacking the PTB sequence affects cellular function. The peptide 
structure suggests it can bind a broad array of distinct peptide ligands (24, 25) however 
some of the first evidence to suggest a specific function came from in vitro studies 
showing that m-Numb can bind regions of the Notch intracellular domain (2, 26). Notch 
activity directs cell fate determination, progenitor cell maintenance, proliferation, 
differentiation and apoptosis (27). An important developmental pathway, Notch signaling 
occurs when neighboring cells expressing transmembrane ligands in the Delta and 
Serrate/Jagged family bind the transmembrane Notch receptor, induce the intracellular 
gamma-secretase cleavage of the intracellular domain (NICD), which then translocates to 
the nucleus and with other factors initiates transcription of downstream transcription 
factor harry and enhancer of split (Hes and Hey) related genes which generally inhibit 
differentiation (28, 29). It might be expected then, that loss or gain of NICD function 
through alterations in Numb could in turn skew the final distribution of differentiated 
cells. 
Numb associates with endocytic machinery and can bind the Notch ICD though 
the PTBi. There is now evidence that Numb can directly initiate the degradation of the 
Notch receptor through interactions of the PTBi with the ubiquitin ligase Itch, which 
causes subsequent polyubiquitination and degradation of Notch ICD (13, 30). 
Specifically, protein mutants lacking the critical Itch binding site in the PTB region 
(NbPTBC) or the C-terminal 41 amino acids including the DPF and NPF regions 
(NbC) had no effect on Notch levels at the membrane compared with wild type p66 
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Numb. Interestingly, in contrast to wild type Nbp66 which dramatically reduces 
intracellular levels of Notch, NbPTBC caused increased levels of intracellular Notch. 
An NbC form lacking DPF and NPF sites but intact PTBi, had very little effect on 
overall Notch intracellular levels. In fact, Itch has been shown to facilitate Notch 
trafficking to lysosomes (30-32). As expected then, internalization and recycling of 
Notch to the membrane is constitutive, and both overexpression and RNA interference of 
Numb did not alter Notch internalization. This suggests that Numb is not principally 
involved in Notch receptor internalization, but mainly traffics NICD out of the 
constitutive recycling process towards endosomes, primarily though interactions with 
Itch. 
 Due to the evidence ascribing Notch activation with proliferation and inhibition of 
differentiation, it was assumed for a long time that the Notch inhibitory actions of Numb 
were responsible for both cell fate determination and progenitor cell maintenance through 
interactions with the PTB region. However, given the evidence that Nbp66 Numb, which 
does not contain the PRR sequence, causes Notch ICD ubiquitination and trafficking to 
endosomes, the PRR region may play a more critical role in progenitor renewal. An 
important structure-function study examined the effects of anti-sense morpholino Numb 
knockdown, with re-expression of separate isoforms (Nbp72, 71, 66, 65) in embryonic 
cortical progenitors at e13.5 and from P19 neurons (3). Interestingly, only expression of 
the PRRL isoforms (Nbp72, 71) caused an increased number of neuronal progenitors 
marked by Nestin compared to EGPF transfected controls. Similarly, expression of either 
PRRS isoforms (Nbp65, 66) reduced Nestin positive cells and increased the number 
differentiated cells marked by increased differentiation marker TUJ1. Of particular 
importance, these actions of progenitor renewal and differentiation are Notch-
independent, such that there was no difference between isoforms in downstream Hes1 or 
NICD cofactor CSL activity by luciferase assay. However Numb can alter Notch in these 
conditions as Numb knockdown showed strong luciferase activation of both Hes1 and 
CSL. Last, re-expression of PRRS isoforms not only induced activation of differentiation 
marker Mash1, but also substantially increased neurite outgrowth, in contrast to PRRL 
forms. This “isoform switching” as its become known has been described during other 
tissue development as well, particularly endocrine organs. During pancreas development 
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before the divergence of differentiated endocrine and exocrine cells, both PRRS and 
PRRL isoforms are co-expressed. However, as endocrine glands begin to differentiate the 
PRRL forms diminish while expression of the PRRS isoforms is sustained (5). Also in 
adult mouse testes, Nbp71 is expressed exclusively in germ cells, while somatic cells 
only express PRRS isoforms (4). This all suggests that the cell lineage determination role 
of Numb may be mediated by trafficking Notch ICD for degradation, while the PRR 
plays a still unknown critical role in progenitor cell maintenance, which may be 
independent of Notch signaling events. 
 
Numb controls cell adhesion 
Clearly, Numb has many functions that extend beyond Notch involvement, 
particularly at the cellular membrane. Of particular interest in recent years is the 
involvement of Numb in interacting with cadherins, integrins and actin cytoskeletal 
components. The PTB and C-terminal regions of Numb have been described to bind E- 
and N-Cadherin as well as alpha- and beta-catenin, and are required for maintaining 
proper cellular localization of these proteins and of adherens junctions (33). Also, NUMB 
is critical for adhesion of radial glial cells and proper localization of neuronal progenitors 
(33). Cell adhesion is a critical component of migration, and in a paradoxical role of 
maintaining adherens junctions, NUMB also binds integrin- proteins and facilitates 
endocytosis of these proteins with clathrin coated pits. Downregulation of Numb by 
RNAi reduces integrin endocytosis and impairs migration (34). This process is normally 
regulated with phosphorylation of Numb by aPKC, thus polarization by Par and aPKC 
proteins may not only affect cell fate determination through interruptions in Notch 
signaling, but also promote integrin endocytosis and leading edge migration (34).  
 
Numb and cell cycle control 
Proper control of proliferation and cellular differentiation are critical early events 
in organogenesis. Thus, tumor growth and the development of cancers are particularly 
sensitive to aberrations in proteins such as Numb during development or progenitor 
maintenance in adulthood. Numb has been linked to cell cycle control in several contexts, 
one of which includes binding to the Golgi apparatus protein ACBD3 during mitosis. 
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Through an N-terminal sequence, Numb binds ACBD3 and facilitates dispersion of Golgi 
cisternae during interphase, a critical aspect of cell cycle progression (35). Numb can also 
affect the cell cycle in a more direct manner by altering the stability of tumor suppressor 
p53. In contrast to the role Numb plays in promoting ubiqtuitin-mediated degradation of 
Notch ICD, it has the contradictory role of preventing ubiquitination of P53. This occurs 
through direct inhibition of the ubiquitin ligase MDM2 (36). Numb not only enters a 
trimeric complex with p53 and MDM2 to stabilize and enhance p53 activity, but loss of 
NUMB in human breast tumors is associated with decreased levels of p53, enhanced 
chemoresistance, and poorer disease prognosis (36). Loss of NUMB has been described 
in 50% of human mammary carcinomas within a group of breast cancer patients, clearly 
highlighting its role in maintaining cell cycle progression (37).  
In addition to breast cancer, loss of NUMB has been associated with brain and 
lung cancers. During normal brain development, the Hedgehog signaling pathway 
promotes neuronal progenitor renewal, and aberrant Hedgehog activity, via enhanced 
downstream target Gli1, results in medulloblastoma (38, 39). More recently, it has been 
shown that enhanced GLI1 activity in these medulloblastoma cells is due to loss of 
NUMB in cerebellar granule progenitors, which disrupts normal Itch mediated 
degradation of GLI1 (40). Further, loss of Numb is associated with small cell lung 
carcinomas, where approximately 30% show increases in Notch-mediated signaling 
events (41). This demonstrates Numb can alter proliferation in many contexts, and its loss 
is associated with aggressive cancers, only some of which involve altered Notch 
signaling. 
An understanding of Numb in mammalian physiology has come a long way since 
its first reported role in Notch inhibition and cell fate determination though asymmetric 
division. Importantly, the vast diversity of protein interactions identified are not exclusive 
to neurogenesis, but occur during the development of many other tissues, and for 
convenience, a summary of the understood protein binding domains are illustrated in 
Figure 1.2. The past two years represent the vast majority of the discoveries of the 
diverse cellular functions of Numb, including its importance in human disease. 
Undoubtedly, many new functions await discovery. Chapters 2 and 3 in this present work 
entitled Numb, an endocytic adaptor protein, is critical to maintain cell adhesion in the 
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intermediate lobe of the mouse pituitary, and Numb, an endocytic adaptor protein, is 
highly expressed in pituitary gonadotropes and may influence fertility, respectively, will 
attempt to identify a previously unknown role for Numb during mouse pituitary 
development as well as maintenance of adult hormone secreting cells. With the 
knowledge that NOTCH2 is transiently expressed during early pituitary development 
before hormone cell specification (42) and transgenic overexpression of Notch2 delays 
gonadotrope differentiation (43) we hypothesize that Numb may be required to control 
and inhibit Notch activity following early pituitary organogenesis. Second, cadherin 
expression in the adult pituitary is a critical component of hormone secreting networks 
(44, 45), so we expect NUMB might be required for proper adherens junction formation, 
and proper migration of fully differentiated cells. Third, Numb was identified in a cDNA 
microarray from adult pituitary progenitor/stem cells sorted based on expression of Sca1. 
Adult Sca1 low cells express markers of early progenitors, including Sox2 and Sox9, as 
well as Hes downstream Notch target genes. Numb is enriched in the Sca1 high cell 
fraction (46). We think Numb may normally restrict proliferation of these adult 
progenitor cells by inhibiting Notch signaling. Last, given the importance of PRR isoform 
expression during early organ development and presence of PTB region in many 
contexts, we expect to find an “isoform switch” such that Nbp72 and 71 predominate 
early before hormone specification, and are replaced with Nbp 66 and 65, with higher 
concentrations of PTBi isoforms (Nbp66) near side populations expressing Notch target 
genes. 
 The fourth chapter is this work entitled Aryl hydrocarbon receptor activation 
affects pituitary hormone cell function in vivo and in vitro, addresses a separate, but 
potentially linked pathway, that may exert unique actions in pituitary development and 
function. Interestingly, despite its well-defined role in modulating dioxin responses, the 
aryl hydrocarbon receptor (AhR) has been reported to have important interactions with 
Notch in other tissue contexts. The potent AhR ligand TCDD can induce expression of 
Notch downstream target HES1, at the mRNA and protein level in human mammary 
carcinoma cells, and AhR activity drives proper IL22 secretion in CD4+ T cells, in a 
Notch dependent manner (47, 48). While Notch does have important actions during 
pituitary development as described previously(42, 43), it is intriguing to speculate AhR 
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may directly alter pituitary cell function. Given that AhR and the important aryl 
hydrocarbon interacting protein (AIP) are both expressed in human pituitaries at the 
protein level, and mutations in AIP are associated with pituitary adenomas (49-51), we 
speculate AhR may play an important endogenous role in pituitary hormone cell 
development and responsiveness. Further, there have been a few reports describing 
altered pituitary hormone levels following AhR agonist administration in various animal 
and tissue culture models, including changes in GH, PRL, ACTH, LH and FSH (52-55). 
However, some of these results are conflicting and warrant further study. The work 
described here will attempt to clarify the endocrine disrupting effects of AhR activation 
on pituitary hormone synthesis utilizing a cell culture method, as well as investigate any 
changes in postnatal pituitary hormone cell function by analyzing AhR
-/-
 pituitary 
hormone mRNA levels. We hypothesize levels of the AhR agonist -naphthoflavone 
sufficient to induce downstream target Cyp1a1, will alter GH and PRL mRNA as well as 
protein levels in the GH3 rat somatolactrotroph cell line. Also, in vivo analysis showing 
mRNA changes in AhR
-/-
 pituitaries should compliment the cell culture data. Last, given 
that AIP is believed to restrict AhR transcriptional activity, and that AIP mutations are 
associated with human pituitary adenomas, we would expect to find increased 
































Structure and identified functional domains of NUMB. PTB = phosphotyrosine 
binding domain; PRR = proline rich region.
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Chapter Two: Numb deletion in POMC expressing cells impairs pituitary 
intermediate lobe cell adhesion, progenitor cell localization, and neuro-intermediate 
lobe boundary formation.1 
 
Abstract 
The pituitary gland contains six distinct hormone secreting cell types that are 
essential for basic physiological processes including fertility and responding to stress. 
Formation of hormone secreting cells during development relies on Notch signaling to 
prevent progenitors from prematurely differentiating. The nature of the signal curtailing 
Notch signaling in the pituitary is unknown, but a good candidate is the endocytic adaptor 
protein NUMB. NUMB targets Notch for proteolytic degradation, but it also has a broad 
range of actions, including stabilizing adherens junctions through interactions with 
cadherins and influencing cell proliferation by stabilizing expression of the tumor 
suppressor protein p53. Here, we show NUMB and its closely related homolog 
NUMBLIKE, are expressed in undifferentiated cells during development and later in 
gonadotropes in the anterior lobe and melanotropes of the intermediate lobe. All four 
isoforms of NUMB, are detectable in the pituitary, with the shorter forms becoming more 
prominent after adolescence. Conditionally deleting Numb and Numblike in the 
intermediate lobe melanotropes with Pomc Cre mice dramatically alters the morphology 
of cells in the intermediate lobe, coincident with impaired localization of adherens 
junctions proteins including E-cadherin, N-cadherin, Beta-catenin and Alpha-catenin. 
Strikingly, the border between posterior and intermediate lobes is also disrupted. These 
mice also have disorganized progenitor cells, marked by Sox2, yet proliferation is 
unaffected. Unexpectedly, Notch activity appears normal in conditional knockout mice. 
Thus, Numb is critical for maintaining cell-cell interactions in the pituitary intermediate 
lobe that are essential for proper cell placement. 
 
                                                
1
 This chapter to be published in Molecular Endocrinology (Moran TB, Goldberg LB, 
Serviss SL, Raetzman LT (2011), copyright 2011, The Endocrine Society. Permission to 




The pituitary is considered the master endocrine gland and is a convenient system 
to study cell fate determination due to the temporal and spatial separation of hormone 
producing cell differentiation during development. In the adult, pituitary hormone cell 
number can be altered in response to physiological need, suggesting a tight control of 
progenitor/stem cell maintenance and mobilization is necessary to be maintained 
throughout the life of the animal (56). The five hormone secreting cell types in the 
anterior pituitary, with the hormone they secrete, include corticotropes 
(adrenocorticotrophic hormone, ACTH), thyrotropes (thyroid stimulating hormone, 
TSH), somatotropes (growth hormone, GH), lactotropes (prolactin, PRL), and 
gonadotropes (follicle-stimulating hormone [FSH] and luteinizing hormone [LH]). In 
mice, an additional intermediate lobe exists, and the hormone-secreting cell type is the 
melanotrope, which produces alpha melanocyte-stimulating hormone (MSH) (57, 58). 
ACTH and MSH are alternate cleavage products of the Pomc gene. All cell types in the 
anterior and intermediate lobe develop from a common precursor primordium within the 
oral ectoderm called Rathke’s Pouch (RP), while the posterior lobe is derived from neural 
tissue and contains glial cells known as pituicytes and axonal projections from the 
hypothalamus, which secrete oxytocin and arginine vasopressin.  
In mice, RP begins to invaginate and early differentiation markers are detectable 
at embryonic day 9.5 days (e9.5), including LIM homeodomain transcription factors 
Lhx3, Lhx4 and Isl1, among others (59-61). Subsequent development of the pituitary 
involves an orchestration of many major signaling pathways important in other tissues 
during embryogenesis, including fibroblast growth factors (FGFs), bone morphogenic 
proteins (BMPs), Wnt proteins, Hedgehog factors and Notch receptors and ligands (42, 
43, 62-68). These pathways are all critical for induction of the pituitary from the oral 
ectoderm as well as proper gland structure and size, however coordination of lineage 
determination remains largely unknown. Presently, one of the best-characterized cell 
lineage determinants includes the transcription factor Prophet of Pit1 (Prop1). Mutations 
in Prop1 cause a postnatal dwarf phenotype (69-71) and a reduction in the Pit1 lineage 
hormone producing cells: thyrotropes, somatotropes, and lactotropes. Interestingly, 
NOTCH2 expression is dramatically reduced in the pituitary of Prop1 mouse mutants 
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(42) . Notch signaling also appears to directly regulate Prop1 expression. Loss of the 
essential Notch cofactor Rbp-J (CBF1) impairs Pit1 lineage development, due to loss of 
Prop1 and results in a premature appearance of the corticotrope lineage (67). A similar 
acceleration of corticotrope development is observed only when both Prop1 and the 
prototypical Notch target gene Hes1 are lost (72). Interestingly, complete Hes1 knockouts 
have a replacement of melanotropes in the intermediate lobe with somatotropes, 
suggesting proper intermediate lobe development is also Notch-dependent (68). Finally, a 
reduction in Notch signaling is necessary for final differentiation of post-mitotic PIT1 
cells and gonadotropes (67) (43). Notch signaling therefore cooperates with Prop1 and 
modifies its expression level. This ultimately influences pituitary cell differentiation in 
the PIT1 lineage, gonadotrope development timing, and corticotrope and melanotrope 
identity. 
Notch signaling pathway components expressed in the developing pituitary 
include the receptors Notch 2 and 3, the delta-like 1 ligand and downstream targets Hes 
and Hey genes, and are detectable from early pituitary formation in the mouse at e9.5 but 
diminish by e13.5-14.5 (42, 67). Recent data suggests that Notch signaling becomes 
active again in the adult pituitary and may be present in an adult pituitary stem cell side 
population (73, 74). This population of multipotent cells are Sox2 positive and can 
differentiate into several hormone producing cells in culture, which represent a putative 
source by which hormone producing cells can be generated in the adult during times of 
physiological stress (46, 75, 76). Tight regulation of Notch activity, then, is important for 
cell fate determination in progenitor cells, including, potentially, stem cells, and improper 
Notch activation has been implicated in tumor formation (77, 78). The protein Numb is a 
Notch antagonist and represents a strong candidate for controlling Notch activity in the 
pituitary. 
The adaptor protein Numb was first identified as an important mediator of 
asymmetric cell division in Drosophila. Through interactions with the partition defective 
(Par) complex including Par3, Par6 and atypical protein kinase C (aPKC), d-NUMB is 
preferentially segregated to, and necessary for, the differentiation of one of two sensory 
organ precursor daughter cells (16, 79). There is also evidence to suggest asymmetric 
Numb segregation following mitosis in mammals. During neurogenesis in mice, 
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asymmetric divisions producing a neuron and progenitor cell showed asymmetric 
localization of Numb to the differentiating cell. However, during symmetric divisions 
producing two neuron daughter cells, Numb was segregated to both daughter cells (22). 
One hypothesis is that cell fate is altered in progeny inheriting Numb. Numb induces 
degradation of the Notch receptor, thereby inhibiting Notch signaling, and promoting cell 
differentiation. When Numb was conditionally deleted in developing neurons, however, 
roles for promoting as well as inhibiting progenitor cell maintenance were uncovered (19-
21). It has been suggested these different roles of Numb may also be due in part to the 
expression of multiple isoforms, two of which differ in sequence in the phosphotyrosine-
binding (PTB) domain, and two which have alternate sequences in a proline-rich region 
(PRR). The functions of these regions are only beginning to be understood but evidence 
suggests the longer PTB form is important in degradation of the Notch intracellular 
domain though interactions with ubiquitin ligase Itch (13, 30), as well as localizing 
NUMB to the plasma membrane (8) and interactions with integrin and cadherin proteins 
(34, 80). Additional progenitor maintenance properties of Numb may be directed by the 
longer PRR isoforms. During early mouse pancreas development before endocrine cell 
specification, both long and short forms of PRR are present, however, following the onset 
of endocrine cell specification, expression of the long PRR isoform is drastically reduced 
(5). Similarly, in mouse male germ cells, the longer PRR form is highly expressed 
compared to a germ cell depleted testis (4). Lastly, in mouse cortical neuron cultures, 
over-expression of Numb lacking the PRR region correlated with higher levels of 
differentiation transcription factor MASH1, and also enhanced neurite outgrowth 
compared with forms containing PRR (3). Together, this suggests the PTB region is 
important for cell adhesion and membrane localization while the PRR region, by some 
yet undetermined mechanism, influences progenitor maintenance and differentiation. 
In part due to recent developments of identifying protein binding domains and 
isoform variants, it has become clearer that Numb has a broad range of functions that 
extends beyond restraining Notch signaling during asymmetric division, which may help 
to explain its diverse roles in many developmental and adult contexts. Numb interacts 
with other proteins in addition to Notch to regulate their ubiquitination status. 
Importantly, loss of NUMB is associated with cancers of salivary gland, lung, and breast, 
 17
many of which are due to increased p53 degradation (36, 37, 81, 82). NUMB also 
interacts with cadherins and is necessary for proper cadherin membrane localization and 
cell adhesion (33), and evidence suggests NUMB partially controls epithelial to 
mesenchymal like transitions and alters cell migration as well (80). Therefore delineating 
the functions of NUMB is important not only for understanding progenitor cell 
maintenance during development, but also adhesion and cell cycle control in adulthood. 
The present study examines Numb protein expression during mouse pituitary 
development and in adulthood. We show that NUMB and NUMBLIKE are expressed 
early in pituitary development before hormone cell specification, and that all isoforms are 
detectable before birth. These isoforms also exhibit dynamic expression patterns such that 
the shorter PTB and PRR forms are more prevalent than longer forms into adulthood. 
Interestingly, conditionally deleting Numb and Numblike from the developing 
corticotropes and melanotropes, has identified a seemingly Notch-independent function 
for these proteins in the intermediate lobe. Specifically, loss of Numb and Numblike 
shows the importance of these genes in maintaining cell adhesion proteins, facilitating 
proper localization of Sox2 positive progenitor cells, and establishing the posterior-
intermediate lobe boundary. 
 
Results 
Numb Expression Patterns in the Developing Pituitary 
In order to visualize the expression of NUMB during the course of pituitary 
development and localize its expression, whole embryos were sectioned and stained using 
immunohistochemistry. NUMB and NUMBLIKE immunoreactivity were examined 
beginning from e9.5, where strong staining could be detected throughout Rathke’s Pouch 
(RP) (Figure 2.1A,D). Positive staining is readily observed in the diencephalon as well, 
particularly in the ventricular zone (arrow, 1A). The veracity of NUMB 
immunoreactivity was confirmed by a second NUMB antibody as well as in-situ 
hybridization. NUMB protein (Figure 2.7A) and mRNA (Figure 2.7C) appear 
sporadically expressed throughout RP in midsagittal sections at e10.5, whereas in more 
peripheral sections, NUMB protein (Figure 2.7B) and mRNA (Figure 2.7D) are more 
limited to the outer border of the gland. At e11.5, NUMB and NUMBLIKE expression 
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appear reduced in RP and only a few positive cells are observed in the diencephalon 
(Figure 2.1B,E). NUMBLIKE expression is still observed at the outer border and luminal 
side of RP, and less so in the area to become the future anterior lobe (AL). One day later, 
at e12.5, NUMB staining is similar with the exception of some positive cells at the border 
between the future intermediate lobe and posterior lobe (PL, Figure 2.1C). NUMBLIKE 
staining is also similar at e12.5 with positive staining at luminal and outer borders and 
very little around the developing anterior lobe (Figure 2.1F).  
 
Numb isoform switch during development 
There are at least four isoforms of NUMB, each displaying a dynamic expression 
pattern in tissues during development and in tumor formation. These isoforms are 
distinguished by the presence or absence of a 48 amino acid sequence in the proline rich 
region (PRR) and the presence or absence of an 11 amino acid sequence in the 
phosphotyrosine binding (PTB) region (Figure 2.2). Due to the fact the antibodies used in 
this study recognize sequences outside of the PTB and PRR, to investigate isoform 
expression during pituitary development, we performed reverse transcriptase PCR on 
cDNA prepared from samples from embryonic day 16.5, postnatal day 1 and 9 and finally 
the adult pituitary. 
We observed that during development there is a switch in isoform expression. For 
the PRR isoforms, the PRRS is present in the pituitary at all ages examined (Figure 2.2). 
The PRRL isoform is most prevalent at e16.5 and P1. We begin to see a decline in PRR-
long at P9 and it is detectable only at low levels in the adult pituitary. For the PTB 
isoforms, at embryonic day 16.5 and P1, the PTBS and PTBL isoforms appear expressed 
at approximately equal levels (Figure 2.2). At P9, the expression pattern shifts so that the 
upper band, representing PTBL is diminished. In the adult pituitary, there is still the 
diminished expression of the upper band, however, there also appears to be increased 
expression of the lower band, representing PTBS. Data from a recent microarray analysis 
of adult pituitaries identified Numb in a sub-population of cells and partially supports our 




Numb and Hormone Co-Localization 
Numb has been shown to play a role not only in embryonic development, but also 
in adult tissues, therefore, we examined the expression of NUMB in the adult pituitary. In 
the mature adult anterior pituitary there are five cell types, each of which secrete a 
specific hormone: ACTH, GH, TSH, LH, PRL, or FSH. NUMB (red) co-localizes with 
many, but not all, LHb and FSHb (green) producing cells (Figure 2.3A,B, open 
arrowhead). There are some NUMB negative and LHb and FSHb singly positive cells 
(Figure 2.3A,B, arrow), as well as some NUMB positive and LHb and FSHb negative 
cells (Figure 2.3A,B, closed arrowhead). NUMB is not detected in any other hormone-
producing cell in the anterior lobe (Figure 2.3C-F).  Co-stains with alpha glycoprotein 
subunit (-GSU, dimerization partner for TSHb, FSHb and LHb) show some co-
localization with NUMB, and provide further evidence NUMB is expressed in 
gonadotropes (data not shown). NUMBLIKE was not detected in hormone producing 
cells of the anterior lobe by immunostaining (data not shown). 
 
Pomc Cre specific deletion of Numb and Numblike alters adhesion and boundary 
formation 
 From the hormone colocalization data we were able to identify that NUMB (red) 
is present in many POMC expressing cells (green) of the intermediate lobe (Figure 2.4A), 
despite a lack of NUMB staining in POMC cells of the anterior lobe. We did not observe 
any NUMBLIKE immunostaining in the intermediate lobe. Using this information we 
employed a Pomc Cre to selectively knock out Numb and Numblike in these POMC 
expressing melanotropes in the pituitary (18, 83). In addition to the intermediate lobe, 
Numb and Numblike will also be eliminated from the Pomc containing neurons in the 
hypothalamus. However, POMC neurons are not known to innervate or directly affect 
intermediate lobe cells, which are instead innervated by dopaminergic, serotonergic, and 
GABA-ergic neurons (84-88). Further, POMC neurons of the arcuate nucleus are of 
different developmental origin, and can function independently from the pituitary. Mice 
deficient in Mash1 show a lack of POMC neuron differentiation despite normal POMC 
expression in the pituitary (89). Also, loss of glucose sensing in POMC neurons results in 
impaired glucose tolerance, yet appears to have little consequence on pituitary function as 
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shown by normal corticosterone levels (90). These data suggest any pituitary effects 
observed in these Numb and Numblike Pomc Cre conditional knockout, should be 
intrinsic. 
We examined the adult pituitary of conditional double knockout (cDKO) (Numb 
fl/fl Numblike fl/fl Pomc Cre) or control (Numb fl/fl Numblike fl/fl) littermate mice for 
hormone staining as well as morphological differences. In cDKO intermediate lobes at 
postnatal day 30, we find that the melanotropes are specified in the absence of Numb 
(Figure 2.4B, green) and that NUMB expression is absent from almost all melanotropes 
(Figure 2.4B, red). On occasion, a large NUMB/POMC double-labeled cell can be 
observed in the cDKO intermediate lobes (box, 2.4B). The cDKO melanotropes also 
appear disorganized as confirmed by H&E stain (Figure 2.4C,D) and are less dense. 
Manual cell counts of DAPI stained nuclei reinforced the observation that the cDKO 
intermediate lobes had significantly fewer cells per area (42± 2.8 and 34 ± 2.1 cells per 
square inch for control and cDKO respectively; P < 0.05). As expected, NUMB 
expression is maintained in the anterior lobe of cDKO animals (Figure 2.4B), as NUMB 
does not colocalize with ACTH producing cells. The conditional knockout strategy 
includes one loxP site upstream of the ATG initiation codon and one loxP site within part 
of the PTB sequence (Figure 2.4E). The antibodies used in this study recognize NUMB 
peptides downstream of the PRR. Also shown is confirmation of deletion at the genomic 
level by PCR from DNA isolated from whole pituitaries (Figure 2.4E). 
Knowing that NUMB is important for maintaining adherens junctions in radial 
glial cells(33), several adhesion markers were investigated by immunohistochemistry in 
the cDKO pituitaries. Compared to control samples (Figure 2.5A), cDKO intermediate 
lobes have dysregulated E-CADHERIN expression (Figure 2.5B). Notably, there appears 
to be increased E-CADHERIN expression throughout the intermediate lobe, yet it is more 
diffuse and less localized to the membrane than the restricted border of E-CADHERIN 
positive cells in the control. In contrast to upregulated E-CADHERIN, other components 
of adherens junctions appear dramatically downregulated. In the control, N-CADHERIN 
is present on the membrane of virtually all cells in the intermediate lobe, as well as the 
PL and AL (Figure 2.5C).  In contrast, the cDKO has a loss of membrane N-CADHERIN 
expression exclusively in the intermediate lobe cells (Figure 2.5D).  A similar pattern is 
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seen for BETA-CATENIN, localized to the cell membrane of control IL cells (Figure 
2.5E), compared with a selective loss in the IL of the cDKO (Figure 2.5F).  Finally, 
ALPHA-CATENIN is similarly lost in the IL cells of the cDKO (Figure 2.5H), compared 
to the uniform expression seen in the control (Figure 2.5G). To investigate the impact of 
the loss of adherens junction proteins on the integrity of the posterior-intermediate lobe 
boundary, the location of the neuron terminals containing arginine vasopressin (AVP) 
was examined.  AVP neurons (red) exclusively terminate in the PL of the control mice 
(Figure 2.5I) and are distinct from the POMC cells (green) in the IL. In contrast, cDKO 
pituitaries contain AVP immunoreactive axon terminals (red) extending into the IL, 
intermixed with POMC cells, and occasional large POMC cells in the PL (Figure 2.5J). 
Mice were also analyzed at P90 and P180 and adhesion phenotypes were similar to P30 
(data not shown). Also, no differences between male and female mice were observed. 
Numb, then, appears critical to maintain cell-cell adhesion and proper separation of the 
posterior lobe from intermediate lobe. 
 
Numb affects pituitary progenitor cell organization  
 Given that Numb affects progenitor and differentiated cell distribution during 
neurogenesis, and that we see reduced membrane localization of adhesion molecules in 
the cDKO pituitary, we investigated the distribution of Sox2 positive stem-like progenitor 
cells in the intermediate lobe (46, 76). Sox2 progenitor cells in the pituitary can also be 
E-cadherin positive (76) so we speculated that dysregulated E-CADHERIN in the cDKO 
pituitaries also affects the progenitor cell niche. It has been recently demonstrated that 
Sox2 positive cells in the intermediate lobe are found at the cleft border (46). We confirm 
this result in control animals by Sox2 immunostaining (Figure 2.6A), however in cDKO 
intermediate lobes, Sox2 positive cells are often observed throughout the intermediate 
lobe rather than confined to the lumen border (Figure 2.6B, arrowheads). The level of 
Sox2 mRNA from the whole pituitary, however, appears unchanged (Figure 2.6, graph). 
Finding disorganized progenitor cells and improper E-CADHERIN expression, it was 
logical to speculate the niche of the Sox2 containing progenitor cells is disrupted, which 
might have downstream consequences on aspects of their behavior, such as proliferation. 
At P30, Ki67 positive cells are scattered throughout the intermediate lobe, not confined to 
 22
the Sox2 positive cells, and are approximately equal in location and number between 
control and cDKO animals (Figure 2.6C, D, graph).  These data indicate that although 
Numb is necessary for intermediate lobe architecture and cell placement, cell proliferation 
is not controlled by these elements.   
 
Numb actions on Notch activity 
 One of the best-characterized actions of Numb is to inhibit Notch signaling, 
therefore we questioned whether Numb normally suppresses Notch receptor actions and 
expression of downstream Notch targets in the pituitary. Notch2 is important for early 
pituitary development, yet becomes undetectable after embryonic day 14.5(42, 43). 
Therefore, Numb expression in the adult intermediate lobe may act in part to reduce 
expression of Notch receptors. We found no differences in Notch2 or downstream targets 
Hes1, HeyL, Hey1 and Hey2 mRNA between control and cDKO pituitaries isolated at 
P30 (Figure 2.8), or by immunostaining for NOTCH2 in POMC expressing cells (data 




 Numb is a complex evolutionarily conserved adaptor protein with important 
actions during embryonic development. This includes facilitating asymmetric cell 
division, cell adhesion and migration, endocytosis, and ubiquitination (13, 16, 22, 30, 33, 
34, 79, 80). Numb does this through interactions with several pathways including Notch, 
Hedgehog, cadherins and p53(13, 30, 33, 34, 36, 37, 40, 80-82). Although the function of 
Numb during embryogenesis in other tissues has been well characterized, its role in 
differentiated cells is less well understood. The present study represents, to the best of our 
knowledge, the first characterization of NUMB expression and function in the pituitary. 
In the postnatal pituitary, we observe NUMB staining in gonadotropes as well as 
sporadically in the intermediate lobe. We show that loss of NUMB in the mouse 
intermediate lobe melanotropes dramatically alters cell adhesion, progenitor cell 
localization and results in posterior-intermediate lobe cell intermixing.  
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NUMB contains multiple protein interaction domains, allowing for a diverse 
range of functions. A domain that mediates many actions of NUMB is the 
phosphotyrosine binding (PTB) region. This area is best known to be critical for inducing 
Notch degradation, although it is also involved with localizing NUMB to the plasma 
membrane and interactions with integrin and cadherin proteins (8, 13, 30, 34, 80). The 
PTB region can be subject to alternative splicing and the longer form is required for Itch-
mediated ubiquitination and endosome trafficking of NOTCH1 for degradation(13, 30). 
We find strongest expression of the longer isoform (PTBL) before and at birth, with a 
decline, but not complete loss, into adulthood. It is known that the Notch signaling 
pathway is critical for early pituitary formation (42, 43, 67), but becomes largely 
undetectable after e14.5, and can be found in isolated pituitary stem cells (46, 73, 74). 
Although Numb and Notch signaling components appear to be expressed in the same 
location of the developing pituitary, it is unknown if Numb affects Notch signaling at that 
time. It may be that Numb controls two distinct but related functions of Notch during 
embryogenesis and adulthood via PTBL: hormone cell specification and stem cell 
maintenance respectively. Based on our data, if the PTB is important for modulating 
Notch activity and transcriptional activation in adult pituitaries, it is likely occurring in a 
population of cells not expressing POMC. However, we cannot exclude the possibility of 
other unknown proteins restoring Notch activity and compensating for the loss of Numb, 
or of changes in RNA expression undetectable by our whole pituitary RTPCR analysis.  
As previously mentioned, the PTB region is not only involved with NOTCH 
degradation, but can also bind cadherins (80). Following deletion of Numb in the 
intermediate lobe, we find altered E-CADHERIN with a loss of additional adhesion 
molecules including N-CADHERIN, BETA-CATENIN and ALPHA-CATENIN. Based 
on our isoform analysis, it is possible the residual PTBL form detectable in adulthood is 
required for proper localization of these adhesion molecules. Likely as a result of these 
disrupted adhesion proteins, cellular organization in these cDKO intermediate lobes is 
highly disordered and the cells are significantly less dense. This corroborates with 
previous studies showing Numb is required for proper cadherin protein function and 
localization (33, 80). Strikingly, cDKO pituitaries show extensive mixing of POMC cells 
with posterior lobe projections expressing AVP, and many large irregularly shaped 
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POMC cells are evident in the posterior lobe region. One possible explanation might be 
some posterior lobe axon terminals receive improper guidance cues from pituicytes, 
which could be mislocalized to the intermediate lobe of cDKO mice. In another study, 
mice deficient in a protein necessary for docking and fusion of secretory vesicles, 
Munc18-1, caused initial establishment of the hypothalamo-neurohypophysial system, 
however before birth posterior lobe axon terminals failed to reach their proper 
targets(91). This demonstrates that communication between posterior lobe axon terminals 
and supporting glial pituicytes is necessary for proper gland formation (91). These results 
all suggest Numb is important for maintaining cell adhesion and pituitary morphology 
and it may have a similar function in other endocrine tissues in which it is expressed, 
such as the pancreas. 
Another region of NUMB that mediates distinct interactions and is subject to 
alternative splicing is the proline rich region (PRR). We find PRRL is most prevalent 
before and shortly after birth with a decline at P9, and it is detectable at low levels in the 
adult pituitary. Previous studies show longer isoforms of PRR occur predominantly in 
progenitor cells, and this expression profile has been supported by experiments in mouse 
pancreas, testes, and neurons (3-5). It is not well understood why PRR is preferentially 
localized to progenitor cells, or how it may promote the maintenance of these cells. 
However, experiments in neuronal progenitors show that Numb knockdown followed by 
re-expression of PRRL isoforms in embryonic cortical progenitors at e13.5 and from P19 
neurons caused an increased number of neuronal progenitors expressing Nestin, and these 
effects are Notch-independent (3). Pituitary progenitor cell maintenance and early 
expansion then may be mediated by PRRL isoforms, and continued expression into 
adulthood may be related to preservation of the small population of Sox2 and Sox9 
positive adult pituitary stem-like cells (46). Recently, it has been shown these Sox2 
positive cells in the adult pituitary can differentiate into several hormone producing cells 
in culture, and are likely important for proliferating and upregulating hormone producing 
cells during times of physiological stress (46, 75, 76). We found a disruption in the 
distribution of Sox2 positive cells, but analysis of whole pituitary samples showed no 
difference in the amount of Sox2 transcription. Numb is then important for maintaining 
the proper Sox2 positive cell niche. This aberrant localization of Sox2 positive cells could 
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be due in part to loss of important Numb-protein interactions in melanotropes, or from 
indirect effects of adhesion impairment by loss of adherens junction proteins. 
One prediction, based on the known functions of Numb, is that intermediate lobe 
hyperplasia or tumors would result when Numb and Numblike are lost. The melanotropes 
are a relatively defined population and serve as a good model to investigate tumor 
formation because many mouse models lacking tumor suppressors are susceptible to 
intermediate lobe tumors (92-98). Recent studies have shown loss of NUMB has been 
implicated in invasive cancers (37, 99). Also there is evidence that Numb normally 
inhibits cell cycle progression through promoting p53 stability (36) and mutations in p53 
are found in approximately 50% of all human malignant tumors (100). Given the role of 
Numb in maintenance of cellular quiescence in other tissues, we looked for differences in 
proliferation in the cDKO pituitaries. Proliferation, marked by Ki67, is unchanged 
between control and cDKO pituitaries. Additionally, no tumor formation is found, at least 
until 6 months of age. Although we did not examine p53 expression, it is known that loss 
of p53 in mice does not cause pituitary tumors, however loss of one or two copies of p53 
can enhance tumor development in mice also heterozygous for the Retinoblastoma gene 
(Rb+/-) (101). Although proliferation remains the same between control and cDKO mice, 
the altered cadherin-catenin protein complex and mislocalized progenitor cells in the 
intermediate lobe parallels the phenotype of loss of Numb in dorsal forebrain radial glial 
cells. In these mice, neocortex rosettes containing progenitor cells, resemble primitive 
neuroectodermal human brain tumors (33). This suggests loss of Numb may not affect 
proliferation directly, but can induce clusters of progenitor cells, which may have an 
increased tendency to proliferate abnormally. The abnormal groupings of Sox2 progenitor 
cells observed in the intermediate lobes of cDKO mice may have an increased likelihood 
of becoming cancerous if subject to an additional mutation or environmental insult 
according to the “hit” hypothesis in cancer development. 
This work identifies NUMB and NUMBLIKE as putative regulatory proteins 
during early pituitary development as well as having critical functions in adulthood in the 
intermediate lobe. The actions of Numb and Numblike are broad, however we show these 
proteins are major components of proper cell adhesion in the pituitary intermediate lobe. 
NUMB expression in gonadotropes is intriguing, and future studies will attempt to 
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address if the function is unique or similar to that in the intermediate lobe.  Given the 
evidence supporting a role of Notch proteins in cancer and pituitary adult stem cell 
maintenance, this highlights the importance of future studies to understand mechanisms 
by which Numb contributes to normal development and disease in other cell populations 
of the pituitary. 
 
Materials and Methods 
Mice 
CD1 mice from embryonic day 9.5 to 12.5 (e9.5-e12.5), as well as adult 
pituitaries, were fixed in 3.8% formaldehyde for 1-24 hours, dehydrated in ethanol and 
then embedded in paraffin. Sagittal sections of 6 μm were mounted on charged slides and 
prepared for in situ hybridization or immunohistochemistry. 
Pomc Cre mice and Numb and Numblike floxed mice were purchased from 
Jackson Laboratories (18, 83). A breeding colony was established with mice that 
contained both alleles of Numb and Numblike floxed (Numbfl/fl, Numblikefl/fl). These 
mice were bred to mice that had both Numb and Numblike floxed, and also contained the 
Pomc Cre transgene (Pomc Cre Tg; Numbfl/fl, Numblikefl/fl). Numb and Numblike 
floxed as well as Pomc Cre mice were genotyped according to previously published 
protocols (83, 102). All mice were maintained according to the University of Illinois 
IACUC. 
In situ Hybridization 
A sense and anti-sense probe for Numb were prepared from the pCMV-SPORT6 
Vector containing a full-length mouse Numb cDNA (MGI: 3991630, purchased from 
Open Biosystems). The probe was linearized and then transcribed with T7 polymerase in 
the presence of digoxigenin labeled nucleotides to create an anti-sense probe and SP6 
polymerase to create the sense probe. The slides were rehydrated with xylene, followed 
by a gradient of ethanol before equilibrating in phosphate buffered saline (PBS). After 
washing in PBS, the slides were then acetylated, after which a 1:1 solution of 2X 
hybridization solution (Sigma) and deionized formamide was put on each slide and the 
slides were incubated at 57°C. The probes were then denatured for 3 min. and the put on 
the slides under a coverslip overnight at 57°C. For the second day the slides were put in a 
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50% formamide 0.5 X SSC solution at hybridization temperature. The slides were then 
blocked with 10% heat inactivated sheep serum in Tris buffered saline (TBS) containing 
2% bovine serum albumin (BSA) and 0.1% Triton X-100, followed by the application of 
the anti digoxigenin antibody conjugated to alkaline phosphatase (Roche). NBT-BCIP 
was added overnight for detection. Controls that were used included one section that no 
probe was applied to, a section with sense probe, and one with a Mash1 probe that 
showed a consistent level and pattern of staining as previously described (72). 
Immunohistochemistry 
Antibodies used in the studies include: goat polyclonal NUMB antibody (1:3000, 
AbCam), rabbit polyclonal numb antibody (1:200, Upstate), rabbit polyclonal 
NUMBLIKE antibody (1:100, Proteintech Group), rat monoclonal Ki67 (1:100, Dako), 
rabbit polyclonal E-cadherin (1:150, Cell Signaling Technologies), mouse monoclonal N-
cadherin (1:300, Zymed [Invitrogen]), rabbit polyclonal Beta-catenin (1:200, Cell 
Signaling Technologies) rabbit polyclonal Alpha-catenin (1:100, Santa Cruz), rabbit 
polyclonal arginine vasopressin (1:1000, Millipore), rabbit polyclonal Sox2 (1:400, 
Millipore). Hormone antibodies used include rabbit polyclonal GH, LH, PRL, TSH 
(1:1000, National Hormone and Peptide Program, NIDDK, Dr. A Parlow) and POMC 
(1:3000, DAKO). 
To detect protein localization, slides were deparaffinized in xylene and rehydrated 
in a gradient of ethanol before equilibrating in PBS. For Ki67, E-cadherin, N-cadherin, 
Beta-catenin, Alpha-catenin, Sox2 staining procedures, slides were boiled in 0.01 M 
citric acid for 5-10 min. then allowed to cool for 10 min. All slides were then blocked in a 
suppressor serum of PBS containing 3% BSA, 0.1% Triton X-100 (IHCB), and 5% 
normal donkey serum. Then slides were incubated overnight at 4°C with the primary 
antibody diluted in IHCB. Primary antibodies were detected with either direct Cy3 or 
DyLight 488 conjugated (1:300) or biotin conjugated secondary antibodies, biotin-rabbit 
(1:250), biotin-goat (1:400), biotin-rat (1:250), biotin-mouse (1:200) and then amplified 
with either Streptavidin Cy3 or Strepavidin DyLight 488 (1:250). All secondary 
antibodies were obtained from Jackson Immunoresearch. During staining, slides are 
washed in PBS containing 0.05% Tween-20 and mounted in an aqueous florescence 
mounting media. These experiments were completed a minimum of three times on 
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independent samples, with 2 sections per sample being examined.  Controls for single 
channel labeling involved running a sample in the absence of primary antibody. Controls 
for the rabbit double labeling included samples without each primary as well as samples 
lacking both primary antibodies, with a one hour blocking period between primary and 
detection antibodies using Donkey anti-rabbit IgG (1:100 Jackson Immunoresearch). 
 Experiments were viewed at 200x or 400x magnification with a Lecia DM2500 
microscope and photographed with the Retiga 2000R color camera. The pictures were 
acquired in Q- Capture Pro after which they were transferred to Adobe Photoshop. 
Quantification of immuno-positive cells was recorded manually relative to total number 
of nuclei (DAPI) present in a complete 400x image intermediate lobe. For cell density 
quantification, total number of nuclei present in a 400x image of intermediate lobe 
section was compared to area determined using NIH ImageJ. Statistics were performed 
using Statistical Analysis Software (SAS). 
 
Reverse Transcription PCR 
Manually dissected pituitaries were put in RNAlater (Ambion) and stored at -20 
degrees Celsius.  Pituitaries were then moved to lysis solution and, using a homogenizer, 
were mechanically dissociated. An RNAqeous kit (Ambion) was then used to isolate the 
RNA from the homogenized samples. Reverse transcription was then performed to create 
cDNA from 0.5μg of isolated mRNA template.  Following the formation of cDNA a PCR 
reaction was performed with primers for either PRR or PTB isoform of Numb.  The PRR 
primers were: Numb RT-PRR Forward- 5’-CTT GTG TTC CCA GAT CAC CAG-3’. 
Numb RT-PRR Reverse- 5’-CCG CAC ACT CTT TGA CAC TTC-3’. Numb RT-PTB 
Forward- 5’-ATG AGC AAG CAG TGT TGT CCT GG-3’. Numb RT-PTB Reverse- 5’-
ACA GCC ATG AAA CAA TGA CAG-3’ (Bani Yaghoub et al., 2007). The PCR 
conditions for both primer sets used were 92ºC for 3 min (1 cycle), 92ºC for 30sec, 55ºC 
for 30 sec, 72ºC for 30sec (34 cycles), and 72ºC for 10 min.  PCR products were 
visualized on a 2% agarose gel stained with ethidium bromide. 
Real Time PCR 
 RNA and cDNA was prepared from whole pituitaries as described above and all 
pituitaries used for real time analysis came from mice at P27. Samples were run and 
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analyzed on Biorad iCycler IQ. Primer sequences were developed on Beacon Designer 
7.0. Primer sequences are: Sox2 Forward 5’-GGA GAA AGA AGA GGA GAG AG-3’ 
Sox2 Reverse 5’-CTG GCG GAG AAT AGT TGG-3’; GAPDH Forward 5’-GGT GAG 
GCC GGT GCT GAG TAT G-3’ GAPDH Reverse 5’-GAC CCG TTT GGC TCC ACC 
CTT C-3’; Notch2 Forward 5’-TGC CAA TAC TCC ACC TCT C-3’ Notch2 Reverse 5’-
TCC ACT GAC ACT GCT TCC-3’; Hes1 Forward 5’- CTC GCT CAC TTC GGA CTC-
3’, Hes1 Reverse 5’- GTG GGC TAG GGA CTT TAC G-3’; HeyL Forward 5’-GGA 
ACA ACA GAG AAT GAA C-3’, HeyL Reverse 5’- CAG CAG TAG TGA GTA ACC-
3’; Hey1 Forward 5’-CAC GCC ACT ATG CTC AAT G-3’, Hey1 Reverse 5’-CCT TCA 
CCT CAC TGC TCT G-3’; Hey2 Forward 5’-GAT TCC GAG AGT GCT TGA C-3’, 
Hey2 Reverse 5’-AGG TGC TGA GAT GAG AGA C-3’. The PCR conditions for all 
primer sets used were 95ºC for 20sec, 55ºC for 30 sec, 72ºC for 30sec (40 cycles). 
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Numb and Numblike are preferentially expressed early in pituitary development. 
Sagittal sections at e9.5 (A,D), e11.5 (B,E) and e12.5 (C,F) immunostained with Numb 
(A-C) and Numblike (D-F), counterstained with DAPI. Both Numb and Numblike are 
enriched in Rathke’s Pouch (RP) at e9.5. AL = anterior lobe, PL = posterior lobe, arrow = 








Shorter PRR and PTB Numb isoforms become dominant in adulthood. Diagram of 
alternate splicing isoforms for Numb. Reverse transcriptase PCR using primers spanning 
the proline rich region (PRR) and phosphotyrosine binding domain (PTB). Embryonic 
day 16.5 (e16.5), postnatal day 1 (P1), P9, and adult pituitary were analyzed. DNA 








NUMB is expressed in gonadotropes in the anterior lobe. NUMB (red) is expressed in 
many but not all luteinizing hormone (LH, A) and follicle stimulating hormone (FSH, 
B) cells. NUMB is not expressed in prolactin (PRL, C), ACTH (POMC, D), growth 
hormone (GH, E), or thyroid stimulating hormone (TSH, F), producing cells. All 
hormones stained in green. Open arrowheads identify co-localizing cells, arrows show 
hormone positive, NUMB negative cells, while closed arrowheads show NUMB positive, 








Numb deletion in intermediate lobe disrupts melanotropes. NUMB immunostaining 
(red) shows positive cells in IL of control pituitary (A), and conditional knockout 
(cDKO) has reduced NUMB expression in IL (B) but expression in the AL is unaffected. 
Occasionally, large Numb positive cells are detectable in the cDKO intermediate lobe 
(white box, B). POMC immunoreactivity is similar between control (green, A) and 
cDKO (green, B), but occasionally POMC cells are seen in the PL of the mutant. 
Hematoxylin and eosin (H&E) stain showing distinct structures in the control pituitary 
(C). In the cDKO, cells in the IL (D) appear larger and disorganized. Schematic showing 
genomic deletion occurs around ATG start site (E). Deletion fragments of 0.7 and 0.35 kb 
correspond to Numb and Numblike respectively. Black bars within PTB and PRR regions 
represent alternative isoforms and antibodies used in this study recognize Numb C-
terminal to PRR region. AL = anterior lobe, IL = intermediate lobe, PL = posterior lobe. 







Conditional NUMB knockout in intermediate lobe disrupts adherens junctions 
protein expression and alters the posterior  intermediate lobe border. E-CADHERIN 
immunostaining shows limited expression in control IL (A) but enhanced and highly 
disordered expression in the cDKO (B) intermediate lobes. N-CADHERIN (C,D), 
BETA-CATENIN (E,F), and ALPHA-E-CATENIN (G,H) all show disrupted expression 
in the cDKO (D,F,H) compared to control (C,E,G). Arginine vasopressin (AVP, red) 
positive axons located within cDKO IL (J) unlike the control (I). AL = anterior lobe, IL = 








Numb affects pituitary progenitor cell organization but there is no change in 
progenitor cell number or proliferation. SOX2 immunostaining (red) in control 
pituitaries is limited to IL border (A) but is observed throughout cDKO IL (B). Ki67 
immunostaining (green) in cDKO IL (D) does not differ visually compared to control (C). 
Real time PCR of whole pituitaries shows no Sox2 mRNA differences between control 
and cDKO mice (n=4) after normalization to Gapdh. Cell counts of Ki67 positive cells 
compared to total number of IL cells shows proliferation is similar between control and 
cDKO (n=3). AL = anterior lobe, IL = intermediate lobe, PL = posterior lobe. Pictures 








NUMB is expressed in Rathke’s Pouch at e10.5 by immunostaining and in-situ 
hybridization. Midsagittal sections (A,C) show sporadic Numb expression within 
Rathke’s Pouch and along lumen border. Peripheral sections (B,D) shows a stronger outer 








Notch2 and downstream target expression are not altered in Numb conditional 
knockout pituitaries. Real Time PCR shows Notch2 and downstream targets HeyL, 




Chapter Three: Numb, an endocytic adaptor protein, is highly expressed in 
pituitary gonadotropes and may influence fertility 
 
Abstract 
The synthesis and release of the gonadotropins LH and FSH from the anterior pituitary 
are essential for fertility in males and females. Many cases of infertility that present with 
altered gonadotropin levels are idiopathic, making the identification of genes controlling 
gonadotrope development and function critically important. Notch signaling may be 
necessary for early gonadotrope lineage determination, however, it must be suppressed 
for timely hormone production in future gonadotropes. A candidate for suppressing 
Notch activity is the protein Numb, which causes degradation of the Notch receptor 
through polyubiquitination via interactions with the ubiquitin ligase Itch. Data from our 
lab show that Numb is preferentially localized in LH and FSH containing cells in the 
anterior lobe of the mouse pituitary. In the present study, we show by immunostaining 
that Numb is present in the rostral tip thyrotropes beginning at e13.5 and is detectable in 
GSU expressing cells in the anterior lobe beginning at e15.5. To determine the function 
of Numb in the gonadotropes, Cre recombinase driven by the GSU promoter, was used 
to delete Numb and its homolog Numblike (cDKO). At e15.5, Numb expression is 
reduced in cDKO pituitaries and adherens junction proteins are not altered. Finally, 
preliminary results indicate loss of Numb may affect both male and female fertility. Four 
of four male conditional Numb knockouts provided successful breeding, however two 
transgenic males not used for breeding had reduced testis size and low LH levels. Female 
Numb conditional knockouts produce litters, although with a significantly smaller 
number of pups. This study suggests Numb and Numblike may have a previously 
unidentified critical role in pituitary mediated reproduction. 
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Introduction 
The mammalian pituitary is an important endocrine regulator of growth, 
metabolism, response to stress, and fertility. The adult anterior pituitary is composed of 
five hormone cell types, which include corticotropes, thyrotropes, somatotropes, 
lactotropes and gonadotropes. These cells are named after the hormones they secrete, and 
include adrenocorticotrophic hormone (ACTH), thyroid stimulating hormone, (TSH), 
growth hormone (GH), prolactin (PRL), and follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH), respectively. The anterior and intermediate lobes of the 
pituitary develop from a common precursor primordium following an invagination of the 
oral ectoderm called Rathke’s Pouch (RP). At approximately embryonic day 9.5 (e9.5), 
early transcriptional markers are detectable and important for formation of RP, and 
include LIM homeodomain transcription factors Lhx3, Lhx4 and Isl1, among others (59-
61). Hormone production by these cells is largely temporally distinct, and the first 
detectable subunit mRNA expression includes alpha glycoprotein subunit (GSU) at 
e12.5. This is a required subunit for TSH in thyrotropes and is also produced in TSH 
containing cells in the functionally distinct rostral tip thyrotropes. Expression of GSU is 
also a critical subunit for both functional LH and FSH, produced in gonadotropes. 
Detectable levels of TSH occur around e14.5 and LH and FSH are detectable at e16.5 
and e17.5 respectively (57, 103). 
Gonadotrope lineage determination relies on a concert of extrinsic signaling 
pathways dictating expression of transcription factor gradients within the developing 
pituitary. The homeobox transcription factor Pitx2 is one of the earliest induced genes 
that is necessary for gonadotrope specification.  Mice with hypomorphic expression of 
PITX2 fail to activate transcription of other transcription factors important for 
gonadotrope function including Gata2, Nr5a1 and Egr1 (104). The zinc-finger 
transcription factor GATA2, is a marker of early gondotrope differentiation and relies on 
BMP2 signaling, in addition to PITX2, for its expression. GATA2 has an antagonistic 
role with PIT1, a transcription factor necessary for the specification of thyrotropes, 
somatotropes and lactotropes. Specifically, in the absence of Pit1, more progenitor cells 
assume a gonadotrope fate, presumably due to enhanced GATA2 activity (105). Mice 
with a pituitary specific knockout of Gata2 using the Cre-recombinase under control of 
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the GSU promoter, have reduced gonadotropin levels, yet are fertile suggesting Gata2 
is dispensible for gonadotrope specification (106). Pituitary specific deletion of the 
nuclear receptor Nr5a1 (steroidogenic factor 1 [SF1]) causes a complete lack of LHb and 
FSHb (107), while early growth response 1 (EGR1) is necessary for Lhb but not Fshb 
transcription (108). Additionally, the T-box transcription factor TBX19 normally acts to 
repress gonadotrope development, where loss of TBX19 leads to a conversion of 
intermediate lobe cells into gonadotropes, and overexpression of TBX19 suppresses the 
gonadotrope lineage (109). These factors play a role in proper expression of LH and FSH, 
however other factors clearly must be involved in determining early gonadotrope cell 
fate. 
 There are data to suggest that Notch signaling also plays a role in suppression of 
gonadotrope cell fate. NOTCH2 is expressed between e12.5 and e14.5 in the progenitor 
cells of RP but not in the differentiating hormone producing cells expressing GSU (42), 
Further, persistent Notch2 expression in gonadotropes causes a delay in their 
development (43). Finally, Notch signaling is a critical component of Prop1 activation 
(67) and overexpression of PROP1 under control of the GSU promoter causes reduced 
levels of Lhb and Fshb (110, 111). These results all suggest Notch2 may be necessary for 
early gonadotrope lineage determination but must be extinguished before hormone 
production occurs in GSU positive cells (43). A candidate for suppressing Notch 
activity is the protein NUMB, which causes degradation of the Notch receptor through 
interactions and subsequent polyubiquitination by the ubiquitin ligase ITCH (13, 30). 
Also, NUMB has recently been shown to be present in most, but not all, FSH and LH 
producing cells in the anterior lobe (Chapter 2). We hypothesized NUMB is required for 
gondadotrope differentiation, and maintenance into adulthood by suppressing NOTCH2. 
 Because Numb knockouts die at e11.5, prior to gonadotrope specification (17), we 
chose the GSU Cre to conditionally delete Numb in GSU expressing cells (112). This 
Cre will cause deletion of Numb in the gonadotropes and thyrotropes, although it should 
not affect thyrotrope development as we found no detectable NUMB expression in 
anterior lobe thyrotropes (Chapter 2). Previous groups have used the same GSU Cre 
strain, and found pituitary knockout of floxed Sf1 (SF1
fl/fl
) results in severely hypoplastic 
testes and ovaries, concomitant with decreased levels of LH and FSH (107). Also, GSU 
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 results in reduced Lhb in females but 
normal levels in males.  Interestingly, Esr1 (ER) knockout females have normal serum 
levels of LH and FSH, however have disrupted cyclicity and are infertile (113). Taken 
together, this evidence suggests a pituitary specific deletion of Numb using the GSU-
Cre is an appropriate model to understand the function of NUMB in gonadotropes.  
 Although NUMB plays a critical role in inhibiting Notch function, NUMB is also 
important for endocytosis and receptor trafficking (9, 30). Proteins such as Gli1, p53, and 
E-cadherin can be degraded or altered in expression through a NUMB mediated 
mechanism, and many other protein interactions with NUMB likely exist which have yet 
to be described. The regulation of gonadotropin expression in adults is complex and is 
influenced by pulsatile hypothalamic release of GnRH, and actions of many hormones 
including, activin, inhibin, follistatin, estrogen, and many others (114-116). It is possible 
that NUMB plays multiple roles in the pituitary and could influence LH and FSH 
expression or release independent of Notch signaling. 
 Although not complete, our studies show that Numb is highly expressed in 
gonadotropes at the onset of their differentiation.  Very preliminary results show in the 
absence of Numb there may be fertility problems in females, while males are fertile but 
may have low expression of LH and reduced testis size. These results may or may not be 
related to Notch signaling, and have the potential to uncover a previously unidentified 
role of NUMB in gonadotropin receptor signaling and hormone expression. 
 
Materials and Methods 
Mice 
CD1 mice from embryonic day 13.5 to 15.5 (e13.5-e15.5), as well as adult 
pituitaries, were immediately placed into RNAlater (Ambion) for RNA isolation, or fixed 
in 3.8% formaldehyde for 1-24 hours, dehydrated in ethanol and then embedded in 
paraffin.  Sagittal sections of 6 μm were mounted on charged slides and prepared for 
immunohistochemistry. 
 
GSU-Cre mice were generously provided by the Camper Laboratory (University of 
Michigan) and Numb and Numblike floxed mice were purchased from Jackson 
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Laboratories (18, 83). A breeding colony was established with mice that contained both 




).  These mice were bred to 
mice that had both Numb and Numblike floxed, and also contained the GSU cre 
transgene (GSU-Cre Tg; Numbfl/fl, Numblikefl/fl). Numb and Numblike floxed as well as 
GSU Cre-Tg mice were genotyped according to previously published protocols (102, 
112). All mice were maintained according to the University of Illinois IACUC. 
 
Immunohistochemistry 
Antibodies used in the studies include: rabbit polyclonal NUMB antibody (1:200, 
Upstate), rabbit polyclonal  NUMBLIKE antibody (1:100 Proteintech Group), rabbit 
polyclonal E-cadherin (1:150 Cell Signaling Technologies), mouse monoclonal N-
cadherin (1:300 from Zymed [Invitrogen]). Rabbit polyclonal GSU (National Hormone 
and Peptide Program) antibody was used at 1:1500. 
To detect protein localization, sildes were deparaffinized in xylene and rehydrated 
in a gradient of ethanol before equilibrating in PBS. For E-cadherin and N-cadherin 
staining procedures, slides were boiled in 0.01 M citric acid for 5-10 min. then allowed to 
cool for 10 min. All slides were then blocked in a suppressor serum of PBS containing 
3% BSA, 0.1% Triton X-100 (IHCB), and 5% normal donkey serum. Then slides were 
incubated overnight with the primary antibody diluted in IHCB. Primary antibodies were 
all detected with biotin conjugated secondary antibodies, biotin-rabbit 1:250, biotin-
mouse 1:200 and then amplified with either Streptavidin Cy3 or Streptavidin DyLight 
488, both diluted 1:250. All secondary antibodies were obtained from Jackson 
Immunoresearch. During staining, slides are washed in PBS containing 0.05% Tween-20 
and mounted in an aqueous florescence mounting media. These experiments were 
completed a minimum of three times on independent samples, with 2 sections per sample 
being examined.  Controls for single channel labeling involved running a sample in the 
absence of primary antibody. Controls for the rabbit double labeling included a single 
primary antibody of each, and a sample with no primary antibodies, each of which 
included all secondary and tertiary antibodies. 
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 Experiments were viewed at 200x or 400x magnification with a Lecia DM2500 
microscope and photographed with the Retiga 2000R color camera. The pictures were 
acquired in Q- Capture Pro after which they were transferred to Adobe Photoshop. 
 
Real Time PCR 
 Manually dissected pituitaries were put in RNAlater (Ambion) and stored at -
20°C.  Pituitaries were then moved to lysis solution and, using a homogenizer, the 
pituitaries were mechanically dissociated. An RNaqeous kit (Ambion) was used to isolate 
the RNA from the homogenized samples. Reverse transcription was then performed to 
create cDNA from 1 μg of isolated mRNA template. Samples were run and analyzed on 
Biorad iCycler IQ. Primer sequences were developed on Beacon Designer 7.0. Primer 
sequences are: LH Forward 5’-CCC AGT CTG CAT CAC CTT CAC-3’ LH Reverse 5’- 
GAG GCA CAG GAG GCA AAG C -3’;GAPDH Forward 5’-GGT GAG GCC GGT 
GCT GAG TAT G-3’ GAPDH Reverse 5’-GAC CCG TTT GGC TCC ACC CTT C-3’. 
The PCR conditions for all primer sets used were 95°C for 20sec, 55°C for 30 sec, 72°C 
for 30sec (45 cycles). 
 
Results 
NUMB and NUMBLIKE are differentially expressed during late embryonic 
pituitary development 
 Previously, we showed by immunostaining that NUMB is highly expressed early 
in pituitary development, but becomes largely undetectable in RP by embryonic day 12.5 
(e12.5) (Figure 2.1c). In these studies, we extended our embryonic analysis of NUMB 
expression and observe that it is almost exclusively present in the rostral tip thyrotropes 
(RTT) at e13.5 (Figure 3.1b). NUMBLIKE is expressed at low levels at e12.5 (Figure 
3.1c), but becomes largely undetectable by immunostaining after e13.5 (Figure 3.1d). By 
e15.5 NUMB can be observed in the developing anterior lobe (Figure 3.1e) which are 
largely GSU positive cells (Figure 3.1f). In postnatal day 21 (P21) pituitaries, Numblike 
RNA expression levels are only marginally higher than the negative control (no reverse 
transcriptase, data not shown).). 
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Conditional Deletion of NUMB with GSU-Cre 
 NUMB co-localizes extensively with gonadotropins LHb and FSHb in the adult 
mouse anterior pituitary (Chapter 2), and is expressed in many GSU positive cells in the 
RTT and anterior lobe at e15.5 before LHb and FSHb are detectable by immunostaining 
(Figure 3.1f). Both RTT cells as well as gonadotropes express GSU, making the aGSU 





 e15.5 controls, NUMB is detectable in three independent embryos in the 
anterior lobe, as well as in RTT cells (Figure 3.2a-c). NUMB expression appears to be 




 GSU-Cre (cDKO) 
embryos (Figure 3.2d-f). NUMB does not appear to be dramatically reduced in the RTT 
of conditional knockout embryos, however one conditional knockout may lack NUMB 
expression there (Figure 3.2d). 
 
Adhesion markers are not grossly affected by loss of Numb in embryonic pituitary 
 It has been demonstrated that NUMB is important for the maintenance of cell 
adhesion though interactions with E- and N-cadherin (33, 80) (our results, Chapter 2). At 
embryonic day 14.5, both E- and N-cadherin expression occur predominantly in the 
developing intermediate lobe with some low level expression in the anterior lobe (72) 
(Figure 3.3a,d). Preliminary immunostaining data (n=2) shows that E- (Figure 3.3b, c) 
and N-CADHERIN (Figure 3.3e,f) expression in cDKO embryos is not different 
compared to controls (Figure 3.3a,d).  
 
Numb may affect gonadotrope function in males and females 
 In the adult anterior lobe, NUMB is expressed in many but not all LHb and FSHb 
producing gonadotropes (Chapter 2). Given that NUMB levels are reduced in the cDKO 
pituitaries at e15.5, we have investigated the effects of loss of NUMB on fertility. Very 
preliminary results show two of three cDKO males at p21 have reduced Lhb mRNA 
levels (Figure 3.4 graph and chart). It is interesting to note these same two males had 
reduced testis size as well, and H&E stain shows no evidence of mature sperm (data not 
shown). Thus far four out of four cDKO males used in breeding pairs are fertile. 
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Similarly, female cDKO mice are fertile however so far they have reduced litter size to 
approximately half that of controls . 
  
Discussion 
 The present study provides very preliminary yet fascinating evidence that NUMB 
has an important and previously unidentified role in mammalian fertility. We show that 
NUMB is largely expressed in GSU positive cells in the developing anterior lobe during 
embryogenesis in early gonadotropes. When Numb is absent or reduced in gonadotropes, 
both male and female mice exhibit defects in the pituitary-gonadal axis.  These results are 
even more intriguing when comparing the loss of function phenotype in the intermediate 
lobe of the pituitary. Conditionally deleting NUMB in the POMC expressing MSH cells 
dramatically affected cell adhesion (Chapter 2). However, deleting NUMB in GSU 
positive cells did not affect E- or N-CADHERIN expression or localization and provides 
additional support NUMB likely has a very different role in gonadotrope cells. 
It is intriguing that NUMB is also strongly expressed in the poorly understood 
pars tuberalis (PT) or rostral tip thyrotropes. Recent evidence suggests the PT is involved 
with photoperiodic control of seasonal breeding. Increased secretion of TSH from the PT 
can alter medial basal hypothalamic control of GnRH and ultimately affect LH secretion 
and gonadal growth in the Japanese quail (117), and may alter seasonal breeding in mice 
as well (118). Given that NUMB is present in early gonadotropes as well as the PT and a 
subset of mature gonadotropes in the adult, it is tempting to speculate Numb may be 
involved in the circadian photoperiodic control of reproductive function. 
 There is increasing evidence Numb is critical for p53 stability, and dysregulated 
Numb is associated with human breast cancers (37, 99). However, an interesting link has 
developed suggesting estrogen activity may also be related to Numb function in breast 
cancers. Specifically, there is a significant correlation with higher levels of NUMB, and 
estrogen receptor (ER) and progesterone receptor (PR) expression in a subset of primary 
human breast tumor samples. Further, NUMB negative tumor samples are significantly 
correlated with the triple negative ER, PR and HER2 (human epidermal growth factor 
receptor 2) samples, suggesting a potential functional correlation between ER and PR, 
and Numb (119). NUMB is an endocytic adaptor protein, and may be necessary for 
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localization of proteins or membrane receptor recycling in mammary cells. The actions of 
the estrogen receptor also critically contribute to proliferation in the pituitary and is 
necessary for fertility.  A recent conditional ER knockout in the pituitary using the 
GSU-Cre Tg, shows that LH and FSH serum levels are similar to those in control 
female mice, however these females have irregular estrous cycles and are infertile (113, 
120). Estrogen is a critical mediator of cyclic LH release, and acts at the hypothalamic 
level to alter GnRH levels as well as directly in gonadotropes of the pituitary (121). Both 
ER and ER are expressed in the anterior pituitary (122) however ER is considered to 
be generally more important in pituitary control of fertility as ER but not ER agonists 
induce LH secretion in vitro (123, 124), and ER-/- female mice cannot ovulate and are 
infertile, while ER-/- females do ovulate and are subfertile (125, 126). Therefore NUMB 
and ER may be involved with shared, or disparate pathways to regulate gonadotropin 
expression. 
 Our results, while preliminary, strongly support a role of NUMB in maintaining 
LH expression in males and possibly fertility in females. Given the emerging evidence of 
possible interactions between Numb and ER, we can speculate NUMB may have a 
previously unknown role in maintaining fertility, some of which could be through 
modulations of ER activity. Well known for its nuclear activity, there are some reports 
of a cell membrane bound form of ER (127, 128). Therefore, as a membrane adaptor 
protein, it is possible NUMB could facilitate protein interactions with a membrane ER 
form. Also, NUMB has been reported to inhibit ubiquitin ligases, and so may help 
promote the stability of ER, or they may share common targets in a parallel pathway. For 
example, NUMB may interact with GnRH receptor (GnRHR), and like the Notch 
receptor, facilitate its recycling. Estrogen can influence GnRH release at the 
hypothalamic level, and therefore influence GnRHR activation. Finally Notch2 
expression has been reported in the adult pituitary (46), so NUMB may act to limit or 
control Notch activity in gonadotropes. Future experiments will investigate fecundity in 








NUMB is expressed in RTT and GSU positive cells later in development. Sagittal 
view of NUMB immunostaining at e12.5 (1a), NUMB expression is first evident in 
rostral tip thyrotropes (RTT), shown with arrow at e13.5 (1b). NUMBLIKE expression at 
e12.5 (1c) and e13.5 (1d). NUMB expression at e15.5 in RTT and scattered cells in 
anterior lobe (1e). Many NUMB positive anterior lobe cells (red) are also GSU positive 
(green) shown with arrows at e15.5 (1f). Frames 1a, b, c, d photographed 400x, frames 














Loss of NUMB in GSU Cre knockouts. NUMB staining in control e15.5 sagittal 
sections (2a, b, c) compared to conditional knockouts (2d, e, f). Three individuals of each 
genotype are presented.  Loss of NUMB is observed in anterior lobe region, and variably 


















E- and N-CADHERIN are unaffected by loss of NUMB in GSU containing cells. E-
CADHERIN (green) in two independent conditional Numb knockout pituitaries at e15.5 
(3b, c) is indistinguishable from control (3a). N-CADHERIN (red) also appears normal in 
Numb knockout (3e, f) compared to control (3d). 
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Mouse Genotype Relative LH Value Phenotype
N fl/fl Nlk fl/fl 0.93 none
N fl/fl Nlk fl/fl 0.86 none
N fl/fl Nlk fl/fl 1.53 none
N fl/fl Nlk fl/fl +alphaGSUCre 1.10 none
N fl/fl Nlk fl/fl +alphaGSUCre 0.29 sm. testes
































Some evidence that LH may be reduced in NUMB conditional knockout males. Real 
time PCR showing individual relative LH values as calculated by standard delta delta Ct 





Chapter Four: Aryl hydrocarbon receptor activation affects pituitary hormone cell 
function in vivo and in vitro. 
 
Abstract 
Studies investigating environmental contaminants such as dioxins have uncovered much 
about how these factors can disrupt endocrine function and contribute to cancer 
formation. Dioxins have been shown to activate the aryl hydrocarbon receptor (AhR), 
which acts as a transcriptional regulator at xenobiotic response elements in the genome. 
Understanding the effects of AhR activation has been of great interest to the reproductive 
biology community, however studies on mammalian hypothalamic pituitary axis function 
have been severely limited. In the present study, we examined the effect of AhR 
activation on endogenous pituitary hormone expression and proliferation in the GH3 rat 
somato-lactrotroph cell line. We show that nanomolar doses of the reversible AhR 
agonist -naphthoflavone impairs mRNA transcription of PRL and GH, as well as protein 
expression of PRL in GH3 cells. Also, when combined with 100 nM of the partial AhR 
antagonist -naphthoflavone, the suppressive effects on PRL were enhanced while GH 
levels were unchanged compared to control. These changes coincide with a suppression 
of the anti-proliferative signaling cytokine TGFbeta1. In knockout studies, we find that 
female AhR
-/-
 mice do not have significantly different Prl or Gh levels, however there 
seems to be a trend towards increased Gh at postnatal day 90 (P90), with no change in 
Prl. However, AhR
-/-
 mice do have significantly reduced Lh expression at P90. AhR 
interacting protein (AIP) has recently gained much attention following the identification 
of several mutations in a group of patients with pituitary adenomas in Northern Finland, 
and other groups have identified links between aberrant AhR activity and enhanced cell 
cycle progression. Surprisingly, we did not observe an alteration in cellular proliferation 
in GH3 cells treated in culture with beta-napthoflavone via flow cytometric analysis of 
propidium iodide staining. Overall, these results demonstrate that AhR is important for 
proper pituitary hormone cell development and maintenance, and represents a source by 
which environmental dioxins can exert endocrine disrupting effects.  
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Introduction 
The aryl hydrocarbon receptor (AhR) is a basic-helix-loop-helix ligand activated 
transcription factor of the Per-ARNT-Sim (PAS) family, which regulates the response of 
many toxic aromatic hydrocarbons (129, 130). AhR ligands occur in common sources 
including pesticides and tobacco smoke (131). One of the more potent ligands includes 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a contaminant in an herbicide used in the 
Vietnam War. This dioxin is highly metabolically stable and causes several effects 
including thymic atrophy, chloracne, hepatomegaly, cachexia, teratogenic effects, and 
death in severe cases (reviewed in) (132). Activation of AhR mediated transcription 
occurs when a ligand binds inactive cytoplasmic AhR, which is normally associated with 
heat shock protein 90 (Hsp90) and immunophilin-like Ara9 or aryl hydrocarbon receptor 
interacting protein (AIP) (133, 134). This complex then translocates to the nucleus, 
dissociates, and the PAS domain of AhR forms a dimer with the PAS domain of the 
constitutively active nuclear protein aryl hydrocarbon receptor nuclear translocator 
(ARNT). At this point the AhR-ARNT complex binds xenobiotic or dioxin response 
elements (XRE, DRE) and mediates transcription (135, 136). 
There is strong evidence to support a role for AhR in influencing endocrine 
function, particularly with respect to gonadal development and fertility (137-139). 
Female mice exposed to AhR ligands have a depletion of primordial and primary oocytes 
(140), and TCDD treatment causes reduced fecundity (141), cleft clitoris, and vaginal 
mesenchymal threads (142). Also, AhR
-/-
 female mice have reduced conception, litter 
size, and pup survival (143, 144), and have impaired development of mature follicles 
(144-146). Data suggest disruptions in ovarian follicle development is an intrinsic effect, 
and mediated to some extent though interactions with estrogen, and exogenous estradiol 
administration can partially rescue the knockout phenotype (144). AhR can influence 
estrogen actions by directly binding to estrogen receptors and activating or inhibiting 
transcription of estrogen downstream target genes in a ligand and concentration-
dependent manner. Specifically, in MCF-7 breast cancer cells, AhR-ARNT complexes 
associate with both ER and ER in the absence of estrogen and activate transcription at 
estrogen response elements (ERE) with co-activator p300 (147). However when estrogen 
is bound to ER, AhR can inhibit ER-mediated DNA binding. AhR can also affect 
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androgen and progesterone receptor actions (148, 149), further expanding its role as an 
endocrine disruptor. Collectively, AhR is important for reproduction and additionally has 
a vast array of interactions to facilitate or inhibit steroid hormone actions. 
While AhR can dramatically affect reproductive endocrine function, little is 
understood about how AhR regulates pituitary hormone synthesis and secretion. 
Environmentally relevant concentrations of TCDD cause reductions in serum LH and 
FSH levels in preovulatory rats, although it is unknown if the site of action is the 
hypothalamus or pituitary (52). Dioxin effects on the pituitary appear not limited to 
gonadotropins, as TCDD-treated mice have a three-fold increase in POMC mRNA levels, 
and the pituitary cell line AtT-20 show increases in POMC mRNA as well after TCDD 
treatment (53). More recently, two groups looking at rainbow trout pituitaries have found 
somewhat conflicting results. TCDD in nM concentrations causes increased GH and PRL 
mRNA in vitro (54). However, another study found decreased GH and POMC by 
microarray following feeding experiments of the much less potent AhR agonist -
naphthoflavone (55). These results show AhR can alter transcription of many pituitary 
hormones, and differences in magnitude and direction of gene changes may be due to 
ligand or concentration effects. 
Additional evidence highlighting the importance of AhR in normal pituitary 
function came from the identification of germline mutations in AIP, as a cause of familial 
growth hormone secreting pituitary adenomas (51). Two AIP mutations accounted for 
16% of all patients with growth hormone secreting tumors, and remarkably the age of 
diagnosis was significantly lower for patients with AIP mutations with 40% under age 35. 
Moreover, AIP expression is reduced in invasive versus non invasive somatotrophinomas 
(50), and AIP silencing in the somatolactotroph cell line GH3 causes increased 
proliferation (150). While not common in sporadic pituitary adenomas (151, 152), the 
aggressive nature and early onset of pituitary adenomas with AIP mutations clearly 
warrant further investigation on how AhR affects normal pituitary function and 
proliferation. 
Alterations in AhR activity can cause serious health concerns, particularly in 
endocrine, reproductive and hepatic tissues. Studies on the direct actions of AhR in the 
pituitary are limited, however evidence suggests AhR ligands can alter normal pituitary 
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hormone production. Additionally, increased AhR activity, presumably through 
mutations in AIP, may be able to cause adenomas. The present study shows AhR 
activation can alter hormone production in vitro in the pituitary GH3 cell line, as well as 









 mice were generously provided and genotyped by B. Karman and M. I. 
Hernandez from the laboratory of Jodi Flaws, University of Illinois. Mice were originally 
developed from C. Bradfield’s laboratory at the University of Wisconsin, but bred and 
housed for these experiments at the University of Illinois. Pituitaries from mice at 
postnatal day 3 and postnatal day 90 were dissected and stored in RNAlater (Ambion) at -
20°C. All mice were maintained according to the University of Illinois IACUC. 
 
Cell culture  
GH3 cells were obtained from American Type Culture Collection (ATCC; 
Manassas, Virginia). Cells for RNA isolation were plated at 600,000 per well in 12-well 
plates and incubated in DMEM/F12 (1:1) media without phenol red (Hylcone) with 10% 
charcoal dextran treated fetal calf serum and 10 nM, 100 nM, or 1 μM -naphthoflavone 
with or without 100 nM -naphthoflavone for 20 hours. Cells for each condition were 
plated in triplicate. -naphthoflavone (Sigma) and -naphthoflavone (Sigma) were 
dissolved in DMSO and controls were treated in DMSO alone. The final concentration of 
DMSO in media in all conditions was 0.07%.  
 
RNA isolation and QPCR 
RNA isolation from cultured cells was performed by standard Trizol (Invitrogen) 
extraction. Pituitary RNA was isolated with an RNaqeous kit (Ambion) after tissue 
disruption in lysis solution with a homogenizer. cDNA synthesis with 0.5 μg of RNA was 
performed with Superscript II kit (Invitrogen). Samples were run and analyzed on Biorad 




 mice: LH Forward 5’-CCC AGT CTG CAT CAC CTT CAC-3’ LH Reverse 
5’- GAG GCA CAG GAG GCA AAG C -3’; PRL Forward 5’-TCA GCC CAG AAA 
GCA GGG ACA-3’; PRL Reverse 5’- GGC AGT CAC CAG CGG AAC AGA -3’; 
GAPDH Forward 5’-GGT GAG GCC GGT GCT GAG TAT G-3’ GAPDH Reverse 5’-
GAC CCG TTT GGC TCC ACC CTT C-3’. Primer sequences for GH3 culture 
experiments: GH Forward 5’-AGG GCA TCC AGG CTC TGA T-3’; GH Reverse 3’-
GCA TGT TGG CGT CAA ACT TG-3’; PRL Forward 5’-CAT CAA TGA CTG CCC 
CAC TTC-3’; PRL Reverse 5’-CCA AAC TGA GGA TCA GGT TCA AA-3’; ERbeta 
Forward 5’-TTG GTG TGA AGC AAG ATC ACT AGA G-3’; Beta-actin Forward 5’-
AAC CCT AAG GCC AAC CGT GAA AAG-3’; Beta-actin Reverse 5’-CGA CCA GAG 
GCA TAC AGG GAC AAC-3’; TGFbeta1 Forward 5’-TCC AAA CGT CGA GGT 
GAC-3’; TGFbeta1 Reverse 5’-CAG GTG TTG AGC CCT TTC CA-3’; AhR Reverse 
5’-TCG CGT CCT TCT TCA TCC GTT AGC-3’; AhR Forward 5’-TCA CTG CGC 
AGA ATC CCA CAT CC-3’; ERalpha Forward 5’-CCA AAG CCT CGG GAA TGG-5’; 
ERalpha Reverse 5’-AGC TGC GGG CGA TTG AG-3’; ERbeta Reverse 5’-AAC AGG 
GCA GGC ACA ACT G-3’; CYP1A1 Forward 5’-GTC CCG GAT GTG GCC CTT 
CTC AAA-3’; CYP1A1 Reverse 5’-TAA CTC TTC CCT GGA TGC CTT CAA-3’; The 
PCR conditions for all primer sets used were 95 degC for 20sec, 55 degC for 30 sec, 
72degC for 30sec (45 cycles). 
Data were analyzed according to standard delta delta CT method with n=3 for 
each experimental condition and graphed. Error bars show standard error of mean and 
statistical analysis was done using analysis of variance (ANOVA) using SAS. 
 
Western Blot Analysis 
 Cells were plated as described above, however cells in both standard media 
(DMEM/F12 (1:1) with phenol red, 10% fetal calf serum) and charcoal dextran treated 
serum in DMEM/F12 (1:1) without phenol red were analyzed. Treatments included 10 
nM, 100 nM, or 1 μM -naphthoflavone and DMSO controls for 48 hours. Cells were 
then removed from plates with trypsin, washed twice in phosphate-buffered saline (PBS) 
and lysed in 400 mM NaCl RIPA buffer (Thermo Scientific) for 20 min. on ice with 
(1:100) mammalian protease inhibitor cocktail (Sigma). The lysate was centrifuged 
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(12,000 RPM, 15 min. at 4°C) and protein concentration of the supernatant was 
determined via Protein Assay (Biorad). Protein extracts were run on 4-20% SDS Page 
gels with 14 μg per well and transferred to nitrocellulose transfer membrane (GE). Blots 
were blocked in 5% milk 50 mM Tris pH 7.5 150 mM NaCl 0.5% Tween 20 (wash 
buffer) for 1 hour. Beta-tubulin rabbit polyclonal (Santa Cruz) was incubated overnight 
4°C in wash buffer without milk at 1:2000. Rabbit polyclonal PRL (National Hormone 
and Peptide Program) used at 1:2000 was incubated in wash buffer the next day at room 
temperature for 1 hour. Secondary antibody for detection was goat anti-rabbit IRDye 
800CW (Odyssey). Protein bands were recorded using an Odyssey LI-COR infrared 
scanner and band intensities were quantified via Odyssey 2.1 software. 
 
 
Cell culture for cell cycle analysis 
GH3 cells were plated at 250,000 cells/well in 12-well plates and serum starved 
for 3 days in 0.1% serum to synchronize cell cycles prior to 3 days of  naphthoflavone 
treatment in either standard media (DMEM/F12 (1:1) with phenol red) or with charcoal 
dextran stripped serum and phenol red free media. Cells were stained in propidium iodide 
after 3 days of  naphthoflavone treatment and analyzed by flow cytometry. Cell cycle 




-naphthoflavone, and when combined with -naphthoflavone, activates CYP1A1, 
suppresses AhR, and does not dramatically affect ER expression 
 Expression of CYP1A1 (cytochrome P4501A1) is the most well known and 
commonly used indicator of AhR activation in vivo and in culture (153-155). In fact, 
adult mouse pituitaries exhibit a robust induction of Cyp1a1 following TCDD treatment 
(53). To determine if the somatolactotrope GH3 cells also respond to AhR activation, 
cells were treated with -naphthoflavone and -naphthoflavone and the levels of 
CYP1A1 were determined by real time RT-PCR. To reduce the actions of steroid 
hormones, which might alter AhR-mediated effects, select experiments for RTPCR used 
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charcoal dextran treated serum (Figures 4.1-3).  Compared to vehicle treatment, -
naphthoflavone significantly increased Cyp1a1 expression to levels approximately 6-fold 
higher than controls at the highest dose (Figure 4.1a). Interestingly, 100 nM of the partial 
antagonist -naphthoflavone had no effect alone, but significantly enhanced the -
naphthoflavone-induced activation of CYP1A1 to levels approximately 14 fold higher 
than control samples. This shows -naphthoflavone acts as an agonist in this context at 
100 nM.  
It has been reported AhR can upregulate its own expression in the pituitary in 
response to TCDD and -naphthoflavone treatments (53, 55), and altered levels of AhR 
are important to consider when interpreting gene expression changes. In contrast to 
previously reported effects on AhR expression in the whole pituitary (53), we find that 
AhR activation causes suppression of AhR transcription in GH3 cells (Figure 4.1b). 
Strong suppression of AhR is evident in -naphthoflavone plus -naphthoflavone 
conditions, which correlate with the highest CYP1A1 induction. 
Estrogen signaling can have a profound effect on the expression of GH and PRL 
(156, 157). AhR has been reported to interact with both ER and ER, recruit co-
activator p300 to estrogen response elements and initiate transcription in human breast 
cancer-derived MCF-7 cells (147). Therefore, it is useful to determine if AhR is altering 
the expression levels of ER, and subsequently causing indirect effects due to altered ER-
dependent transcriptional events. We find Esr1 (ER) expression levels in GH3 cells are 
significantly reduced at 100 nM of both -naphthoflavone and -naphthoflavone 
treatment, although the reduction is small (Figure 4.1c). Esr2 (ER) is expressed at much 
lower levels than ER, and those levels were not significantly different at any dose (data 
not shown). 
 
Growth hormone and prolactin are differentially affected by AhR activation 
 Based on conflicting results of AhR activation on GH levels in trout pituitary 
cultures and its inductive effects on PRL expression (54, 55), we examined whether -
naphthoflavone with or without -naphthoflavone, alters Gh or Prl mRNA expression in 
GH3 cells. Treatment of GH3 cells with -naphthoflavone significantly reduced Gh 
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expression only with 100 nM -naphthoflavone (Figure 4.2a). Prl, however, was 
significantly suppressed at all concentrations of -naphthoflavone tested, with the 
greatest effects at 100 nM. Adding -naphthoflavone enhanced the suppression of Prl to 
approximately half the expression of DMSO and DMSO plus -naphthoflavone controls. 
This shows AhR activation can significantly reduce Prl but not Gh expression. 
 To determine if factors removed through charcoal dextran treatment might 
differentially affect Gh and Prl transcription compared to standard growth media, GH3 
cells were treated with -naphthoflavone and analyzed after 48 hours in each growth 
media (Figure 4.2b). Gh was not changed in any condition (data not shown), however Prl 
is significantly reduced following 1 μM -naphthoflavone in standard, but not charcoal 
dextran treated media. 
 With the knowledge that AhR activation can suppress prolactin transcription, we 
performed western blot analysis to determine any changes at the protein level. Consistent 
with the 48 hour -naphthoflavone mRNA data, -naphthoflavone did not alter PRL in 
charcoal dextran treated media (Figure 4.2c). However, in standard media conditions, -
naphthoflavone did reduce PRL expression. Western blot band intensities were quantified 
and normalized to beta-tubulin controls using Odyssey 2.1 (LI-COR) software, showing 
that -naphthoflavone at 1 μM reduced PRL to levels on average of 58.4 +/- 14% that of 
DMSO controls, n=3. 
 
AhR suppresses TGF1 
 AhR activation is correlated with decreased expression levels of extracellular 
cytokine transforming growth factor  (TGF), and this may be important for AhR-
mediated pathologies. For example, TCDD treatment causes reduced TGF1 expression 
in epithelial and mesenchymal cells during palatogenesis (158). Additionally, the absense 
of Ahr, in Ahr
-/-
 mice leads to increased TGF levels in fibrotic livers (159). We show -
naphthoflavone at 100 nM can significantly reduce Tgfb1 expression, and -




AhR knockout mice have reduced LH expression at P90 
 As a step toward understanding the physiological role of AhR in the pituitary, we 
examined expression of Gh, Prl, and Lhb, at post natal day 3 (P3), several days after the 
cells are specified, in mice with or without Ahr.  We chose to focus on these hormones 
because of the significant effect loss of AhR has on ovarian physiology, as well as the 
effects on somatolactotropes described here and elsewhere (54, 55). Conflicting evidence 
exists concerning the effects of AhR on gonadotropin levels. TCDD can cause reductions 
in serum LH and FSH levels in preovulatory rats (52). However, in Ahr
-/-
 mice, serum LH 
and FSH levels are relatively normal between ages P25 and P28 (160). We find that at P3 
there is a trend towards reduction of Lhb (p = 0.053) and potentially a reduction of Prl in 
AhR
-/-
 females (Figure 4.4a). At P90, there is a trend towards increased Gh while Lhb is 
significantly reduced in Ahr
-/-
 females (p < 0.001) compared to wild type littermate 
controls (Figure 4.4b). 
 
AhR activation by -naphthoflavone does not alter cell cycle progression in GH3 
cells 
 Specific mutations in AIP are associated with pituitary adenomas (51), where 
presumably AIP no longer sequesters AhR to the cytoplasm and allows enhanced AhR-
mediated transcription. Further, AIP knockdown in GH3 cells enhances proliferation 
(150) and over expression of AhR enhances proliferation in carcinomic human alveolar 
basal epithelial A549 cells and mouse mammary fibroblasts (161, 162). Based on this 
proliferative effect of AhR activation, we investigated if -naphthoflavone following 
three days of treatment enhances cell cycle progression by propidium idodide staining 
and flow cytometric analysis. Our data show that -naphthoflavone at 1 and 10 μM did 
not alter the percentage of cells in G1, S, or G2 phases (Figure 4.5a,b). It is interesting to 
note that there appears to be a small difference between growth media, such that cells 
grown in the standard media tended to have fewer cells in G1 and more in S phase, which 
would be expected given the additional presence of steroid hormones. Overall, this 





The work presented here demonstrates that AhR activity affects pituitary hormone 
production in vitro as well as in vivo. This was first shown by -naphthoflavone 
effectively inducing AhR activation through CYP1A1 expression in GH3 cells, which 
was expected based on previous studies in vivo and in vitro (55, 163). Unexpectedly, the 
AhR antagonist -naphthoflavone had a synergistic effect with -naphthoflavone in 
inducing CYP1A1, yet had no effect on CYP1A1 alone with the same concentration. The 
actions of -naphthoflavone here are contradictory to previous reports of CYP1A1 
induction in GH3 cells (164), however there are several reasons that could account for 
this. The study from Gauger et al. (2007) used PCB congeners for AhR induction and 
was antagonized with -naphthoflavone, so the differences observed here from -
naphthoflavone could be due to different effects between the AhR agonists and -
naphthoflavone. It is possible -naphthoflavone in the presence of different agonists may 
alter AhR conformation and subsequent transcriptional activity. Further, the 
concentrations of -naphthoflavone used in our study of 100 nM was lower than the 1 
μM levels used by Gauger et al. (2007), therefore in our experimental conditions and 
drug concentrations, -naphthoflavone exhibited agonist actions. The GH3 cells 
described here for RTPCR data were cultured in media with serum that had been treated 
with charcoal dextran, which depletes the media of steroid hormones. Other groups have 
used alternate methods of removing steroid hormones including an anion exchange 
column (AG 1-X8 resin), which reduces T3 and T4 levels (164). Therefore it is possible 
different ligands and concentrations of steroid hormones were present during culturing 
conditions between studies. Last, treatments in this study examining mRNA levels were 
acute and consisted of 20 hours, which could have very different effects than studies with 
several day treatments.  
 Robust AhR activation, identified by greatest CYP1A1 induction, occurred in the 
cells treated with 1 μM -naphthoflavone and 100 nM -naphthoflavone. These same 
conditions caused the most Prl gene suppression, yet had very modest effects on Gh 
expression. Further, while a difference in PRL protein expression was not detectable 
following 48 hours of -naphthoflavone treatment in charcoal dextran treated serum 
media, there was an observed suppression of PRL in standard media growth conditions. 
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These results appear to contrast with the reported findings of Elango et al. (2006) in 
which TCDD increases both GH and PRL in vitro, however at very low doses in the 
picomolar range, TCDD may suppress both GH and PRL (54). Also TCDD is a much 
more potent ligand than -naphthoflavone, and therefore, these differences may be dose 
and ligand specific and highlights the importance of understanding “mixture effects.” 
This concept of multiple ligands causing an outcome which is different than the sum of 
each of the independent actions was identified as an important consideration for future 
studies in a recent statement from the Endocrine Society (165). Each study, however, 
provides important insight that AhR can disrupt pituitary hormone synthesis, and the 
differences we observe in PRL but not GH expression may be due to variants in 
xenobiotic response elements for each gene. 
These data identifying a pituitary hormone suppressing effect of AhR activation 
are complemented by the results of our knockout study. While not significant, there was a 
trend towards increased Gh at P90 in Ahr
-/-
 animals. It is interesting to note that this effect 
mirrors to some extent, the significantly decreased Gh mRNA following 100 nM -
naphthoflavone treatment in the GH3 cells. This suggests AhR may normally act to 
subtly modulate, and specifically suppress, GH levels in adult animals. At P3, AhR
-/-
 
females have reduced LH levels, though not statistically significant. However, by P90 Lh 
is suppressed to a significant degree. This not only shows AhR has an important role in 
normal reproductive endocrine function, but may also partially explain the phenotype of 
impaired antral follicle development and reduced corpora lutea in Ahr
-/-
 females (145, 
146). Despite the fact that these mice have normal LH serum levels between P25 and P28 
(160), there may be a progressive pre-pubertal suppression of LH which alters ovarian 
follicle development, before LH levels can be later restored. Further evidence to support 
a role in AhR directing Lh transcription came from studies showing fetal rats had reduced 
Lh mRNA as well as LH serum protein levels following maternal administration of 
TCDD (166, 167). Additional studies to follow Lh mRNA levels in Ahr
-/-
 females during 
puberty and into adulthood could be illuminating on understanding this ovarian 
phenotype. 
 In many ways, the more surprising findings of this study were demonstrated by 
the lack of effects on proliferation following -naphthoflavone treatment. There is 
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considerable evidence showing that AhR activation can promote proliferation. Ahr
+/+
 
mouse mammary fibroblasts are more tumorigenic than Ahr
-/-
 cells (162), and AIP 
knockdown in GH3 cells, which presumably allows enhanced AhR transcription, 
promotes enhanced proliferation three days after transfection (150). Also, mutations in 
AIP have been identified as a cause of familial growth hormone secreting pituitary 
adenomas (51). Further relevant to the data presented here, there is an interesting inverse 
relationship with respect to AhR and TGF levels on proliferation. Experiments using 
primary hepatocytes found increased TGF secretions from Ahr-/- cells and also had 
lower proliferation rates than wild type (168). Additionally, adding a TGF neutralizing 
antibody to Ahr
-/-
 fibroblasts restores proliferation close to wild type levels (162). It has 
been known for some time that TGF can suppress estrogen-induced lactrotrope 
proliferation (169), and these actions are modulated by dopaminergic hypothalamic input 
(170). It is tempting to speculate lactrotrope hyperplasia responsive to TGF 
administration, may also involve altered AhR or AIP activity. In fact, it is possible the 
proliferative effects of AIP silencing occurs in an AhR-independent manner as others 
have shown AIP interacts with phosphodiesterase4A5 and may affect proliferation by 
altering cAMP levels(49, 150) The results described here demonstrating a strong 
suppression of TGF, concomitant with a lack of proliferation changes following AhR 
activation are unexpected given the previous data presented above. However, it is 
possible more efficacious AhR ligands can induce cell cycle progression in GH3 cells, or 
much higher doses of -naphthoflavone would be required than what was used in this 
study.  
Many questions remain to be answered, however the present study demonstrates 
ligand-induced AhR can alter transcription of many pituitary hormones and has little 
effect on pituitary cell proliferation in culture. Future studies examining different AhR 
ligand effects on pituitary hormone response as well as further gene transcription changes 
in AhR
-/-




























-naphthoflavone alone and with -naphthoflavone activates Cyp1a1, suppresses 
AhR expression, and does not dramatically affect Esr1. Real time PCR shows 
significantly higher levels of Cyp1a1 at 1 μM -naphthoflavone and both 100 nM and 1 
μM -naphthoflavone plus 100 nM -naphthoflavone (1a). AhR is significantly reduced 
at 10 nM and 100 nM -naphthoflavone and at all doses of -naphthoflavone plus -
naphthoflavone in cultured GH3 cells (1b), while -naphthoflavone has only a small 
suppressive effect on Esr1 (ER) at 100 nM -naphthoflavone plus 100 nM -
naphthoflavone (1c). mRNA values normalized to beta-actin, cells treated for 20 hours in 




















































Growth hormone and prolactin are suppressed via AhR. Growth hormone mRNA 
levels remained largely unchanged except at 100 nM -naphthoflavone where they are 
significantly reduced. Prl, however, was significantly reduced with all doses of -
naphthoflavone and of -naphthoflavone plus -naphthoflavone in cultured GH3 cells 
(2a). mRNA values normalized to beta-actin, cells treated for 20 hours, n=3. Following 
48 hours treatment in cultured GH3 cells, Prl is suppressed only at 1 μM -
naphthoflavone in standard growth media (2b). Western blot analysis following 48 hour 
treatment in cultured GH3 cells shows PRL is reduced in standard growth media (St.) but 
not in charcoal dextran treated media (C.D.) at 1 μM -naphthoflavone (2c). Average 

























AhR suppresses TGF  mRNA expression. Significant reduction in TGF mRNA 
occurs at 10 nM and 100 nM -naphthoflavone and all doses of -naphthoflavone plus -
naphthoflavone in cultured GH3 cells treated for 20 hours in charcoal dextran treated 

















 females have reduced LH expression at P90. Real time PCR performed on 
isolated P3 pituitaries from Ahr
-/-
 and wildtype littermates shows a trend towards 
decreased Prl and Lh (4a), n=3. RTPCR analysis on isolated pituitaries from P90 females 
shows a trend towards increased Gh and significantly decreased Lhb (p < 0.001) (4b). 












AhR activation via -naphthoflavone does not affect proliferative capacity of GH3 
pituitary cells. -naphthoflavone at 1 and 10 μM does not alter the percentage of GH3 
cells in G1, S, or G2 phases of the cell cycle in either standard (5a) or charcoal dextran 
treated serum medias (5b). Cultured GH3 cells with charcoal dextran treated serum had 




Chapter Five: Concluding Remarks 
The principal findings of Chapters Two and Three include the identification of a 
previously unknown role for the proteins Numb and Numblike during mouse pituitary 
development and adulthood. At the time this project began, Numb was mainly 
characterized as an inhibitor of Notch proteins in neuronal progenitors, influencing 
neuronal progenitor asymmetric cell division. It is now recognized to be an endocytic 
adaptor protein with a broad range of effects in many tissues, with certainly many more 
functions yet to be uncovered. The results here show that conditional loss of Numb and 
Numblike in POMC expressing cells results in pituitary intermediate lobe metaplasia, 
without evidence of hyperplasia. We therefore believe the primary role of Numb in the 
postnatal pituitary intermediate lobe is to maintain stability of adherens junctions proteins 
including N-cadherin, E-cadherin, -catenin, and -catenin as depicted in Figure 5.1. 
These results are not surprising, given the previously described role of Numb and 
adherens junctions proteins in the brain.  
Three major aspects of this study presented in Chapter Two, which were 
unexpected and certainly warrant future investigation, are the lack of observed 
differences in proliferation, cell fate commitment, and Notch activity in P30 cDKO 
compared to control pituitaries. As shown in previous studies, Numb appears to alter 
proliferation through one of two major mechanisms. The first, and representing 
significant recent interest, is from observations of cancer tissues from human patients 
with low or absent levels of Numb compared to normal tissue. This was also shown to be 
due to loss of p53, as Numb can protect p53 ubiquitination by binding and inactivating 
the ubiquitin ligase MDM2. We did not address p53 in this study, however, further 
experiments utilizing co-immunoprecipitations in primary tissues to find if NUMB is 
directly associating with p53 in the pituitary would be useful. It is known that p53 
deficient mice do not get pituitary tumors, but loss of one or two copies can accelerate 
tumor progression in mice heterozygous for the Retinoblastoma gene (Rb+/-). This result 
suggests these cDKO animals may be more susceptible to developing tumors. It is 
interesting to speculate that like tumors of other origins, pituitary adenomas may arise 
from loss of Numb, destabilization of p53, concomitant with another unknown cell cycle 
protein alteration. The second known major mechanism by which Numb can alter 
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proliferation is due to changes in progenitor cell populations, following asymmetric 
division from studies utilizing early conditional Numb deletion in neuronal precursors. 
The isoform data we present, show the longer forms of the proline rich region (PRR) 
which is associated with progenitor cells in other contexts, is most highly expressed in 
embryonic pituitaries whereas the shorter PRR isoform is more highly expressed in 
adulthood. It would be extremely interesting to utilize a pituitary progenitor cell specific 
Cre-recombinase transgenic mouse to conditionally delete Numb in pituitary progenitor 
cells before hormone cell differentiation occurs, and track progenitor cell proliferation, as 
well as hormone cell differentiation with immunohistochemistry. Last, alterations in 
Notch activity determined by immunohistochemistry, in situ hybridization, or laser 
capture microdissection and RTPCR, could determine if Numb does alter Notch activity 
early in pituitary development, and if these changes coincide with the hormone cell 
differentiation changes. Last, these experiments could be supplemented by cell culture 
experiments using either the somatolactotrope, gonadotrope, or corticotrope cell lines, 
whereby Numb expression is knocked down via siRNA or lenti-viral vector, specific 
isoforms could be re-expressed, and changes in Notch downstream targets could be 
quantified by RTPCR concomitant with mRNA changes in pituitary hormones, cell 
adhesion, or other markers. These experiments may yield great insight into the actions of 
transient Notch activity, which immediately precede pituitary hormone cell 
differentiation. 
Preliminary findings related to an additional role of Numb expression in the 
mammalian pituitary are described in Chapter Three, and related to a putative role in 
gonadotrope function. We identify Numb as a protein which is enriched in most, but not 
all LH and FSH positive cells of the mouse pituitary. Further, we have preliminary 
evidence that LH mRNA is suppressed in male cDKO pituitaries using the GSU-Cre 
transgenic. Current ongoing studies include identifying LH mRNA changes in female 
mice as well as female cDKO date of vaginal openings, frequency of estrous cycles, litter 
size, time period between pregnancies, and pup survivals. Finally, both male and female 
cDKO and controls will be sacrificed for reproductive organ pathology, including testes, 
ovaries and pituitaries. These studies have potential to be a highly unique contribution to 
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the reproductive field, and represent the first description of a reproductive phenotype to 
the protein Numb. 
The final research chapter (Four) presents an interesting role for the aryl 
hydrocarbon receptor both as a mediator of exogenous endocrine disruptors, but also as a 
necessary endogenous component of pituitary physiology. Interestingly, we find that not 
only did the putative AhR antagonist -naphthoflavone have synergistic effects at 100 
nM with agonist -naphthoflavone in the pituitary GH3 somatolactotrope cell line, but 
these ligands suppressed prolactin, and not growth hormone. These results are important, 
as they show nanomolar doses of relatively low affinity AhR ligands are capable of 
acting as endocrine disruptors. Additional studies to determine the mechanism by which 
this occurs could include chromatin-immunoprecipitation and identify if AhR is bound to 
xenobiotic response elements proximal to the PRL and GH promoter sequences. 
AhR has also been shown to have a subtle, yet intriguing role in normal pituitary 
function. The real-time PCR data from the AhR
-/-
 pituitaries shows that at P3, LH levels 
are exhibiting a trend towards being low, and by P90 are significantly reduced. These 
results support and may play a role in the impaired ovarian follicular development in 
these mice as described by Benedict et al. (2000). At P90, the AhR
-/-
 pituitary cells are 
fully differentiated, and would more closely be correlated to the -naphthoflavone cell 
culture experiments. Interestingly, PRL and especially GH show trends towards increased 
expression in P90 AhR
-/-
 pituitaries. This might be expected for PRL which was shown to 
be decreased with AhR activation, however is contrary to the lack of effect on GH 
expression we found in the culture experiments. Future studies should include  analyzing 
more AhR
-/-
 pituitaries, increasing sample size at both P3 and P90, but also looking at 
post pubertal female, as well as male, ages. Additionally, a basic pathology analysis of 
these pituitaries could yield interesting data concerning onset, as well as localization of 
hormone producing cells. Finally, despite the lack of evidence showing proliferative 
changes in culture following AhR activation though -naphthoflavone, proliferation of 
one or more particular hormone producing cell types may be altered and should be 
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